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ABSTRACT 
New optical technologies were developed to continuously measure cerebral blood flow 
(CBF) and oxygen metabolism (CMRO2) non-invasively through the skull. Methods and 
devices were created to improve the performance of near-infrared spectroscopy (NIRS) 
and diffuse correlation spectroscopy (DCS) for use in experimental animals and humans. 
These were employed to investigate cerebral metabolism and cerebrovascular reactivity 
under different states of anesthesia and during models of pathological states. 
Burst suppression is a brain state arising naturally in pathological conditions or 
under deep general anesthesia, but its mechanism and consequences are not well 
understood. Electroencephalography (EEG) and cortical hemodynamics were 
simultaneously measured in rats to evaluate the coupling between cerebral oxygen 
metabolism and neuronal activity in the burst suppressed state. EEG bursts were used to 
deconvolve NIRS and DCS signals into the hemodynamic and metabolic response 
function for an individual burst. This response was found to be similar to the 
stereotypical functional hyperemia evoked by normal brain activation. Thus, spontaneous 
  vii 
burst activity does not cause metabolic or hemodynamic dysfunction in the cortex. 
Furthermore, cortical metabolic activity was not associated with the initiation or 
termination of a burst. 
A novel technique, time-domain DCS (TD-DCS), was introduced to significantly 
increase the sensitivity of transcranial CBF measurements to the brain. A new time-
correlated single photon counting (TCSPC) instrument with a custom high coherence 
pulsed laser source was engineered for the first-ever simultaneous measurement of 
photon time of flight and DCS autocorrelation decays. In this new approach, photon time 
tags are exploited to determine path-length-dependent autocorrelation functions. By 
correlating photons according to time of flight, CBF is distinguished from superficial 
blood flow. Experiments in phantoms and animals demonstrate TD-DCS has significantly 
greater sensitivity to the brain than existing transcranial techniques. 
Intracranial pressure (ICP) modulates both steady-state and pulsatile CBF, making 
CBF a potential marker for ICP. In particular, the critical closing pressure (CrCP) has 
been proposed as a surrogate measure of ICP. A new DCS device was developed to 
measure pulsatile CBF non-invasively. A novel method for estimating CrCP and ICP 
from DCS measurement of pulsatile microvascular blood flow in the cerebral cortex was 
demonstrated in rats. 
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CHAPTER ONE: GENERAL INTRODUCTION 
Introduction 
While the brain is only two percent of the body by mass, it consumes a fifth of the 
body’s total cardiac output and oxygen supply (Clarke et al. 1999; Jain et al. 2010; 
Barrett 2009). The brain requires a great proportion of the body’s circulation in part to 
feed the 20 Watts of power it consumes at rest (Clarke et al. 1999). The cerebral 
circulation is also large because it must provide a safety margin to ensure the brain 
parenchyma is always oxygenated adequately. Despite the brain’s high rate of energy 
turnover and a near total reliance on oxidative metabolism, brain tissue contains no 
intracellular stores of oxygen (McKenna et al. 2012). The lack of an intrinsic oxygen 
reserve puts the brain at risk for impairment and irreversible damage from even brief 
interruptions to its oxygen supply and makes maintenance of a large perfusion reserve 
necessary. The close coupling between cerebral function and oxygen transport is evident 
when cerebral blood flow (CBF) stops completely. Consciousness is lost when the 
oxygen in the 70 milliliters of blood retained by the brain has been fully consumed, a 
process which completes within ten seconds of the cessation of CBF (Clarke et al. 1999). 
Clearly, cerebral blood flow and metabolism are essential aspects of brain physiology. 
While the primary responsibility of pulmonary and cardiovascular systems is to 
maintain a continuous supply of oxygen to the brain, these systems act at a global level to 
balance potentially conflicting demands of the brain, other internal organs, and the 
periphery. The central circulatory system’s coarse level of control is inadequate to protect 
the brain from fluctuations in systemic blood supply or to meet rapid increases in local 
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metabolic demand from activated neurons. To augment systemic regulation, the 
vasculature of the brain evolved a unique network of multiple sets of overlapping 
regulatory systems to maintain cerebral perfusion homeostasis and support functional 
brain activity. This network, known collectively as cerebrovascular reactivity, exerts 
exquisite control of cerebral blood flow and oxygenation (Willie et al. 2014). The control 
output of the network is CBF, effected by changes in intracranial vascular resistance. The 
network inputs (mediators) are 1) the arterial partial pressure of CO2 (paCO2) and to a 
lesser extent paO2, 2) cerebral perfusion pressure (CPP), 3) local rates of cerebral 
metabolism, and 4) signals from the autonomic nervous system (Panerai 2003; Ainslie et 
al. 2009). Correspondingly, these regulatory systems are broadly classified as 
chemoregulation, mechano- and auto- regulation, flow-metabolism coupling (or 
neurovascular coupling), and neurogenic control. This network acts through diverse 
mechanisms ranging from the fundamental architecture of the vascular anatomy itself to 
various cellular and molecular pathways which have yet to be elucidated fully. Its 
impairment is implicated in diseases ranging from complications of premature birth 
(Brew et al. 2014; Greisen, 2009) to traumatic brain injury (Lam, 2011), stroke (Kunz et 
al. 2009), and Alzheimer's disease (Iadecola, 2004). 
Cerebral blood flow and metabolism are important topics of basic and clinical 
research. However, even after decades of investigation, much remains fundamentally 
unknown about their mechanisms of regulation. The pathways of cerebrovascular 
reactivity are difficult to follow because their heterogenous and overlapping networks 
involve many different mediators, cell types, and tissues. This complex milieu makes full 
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recapitulation of cerebrovascular reactivity impossible in in vitro models such as brain 
slices. The studies described in this thesis were designed to facilitate in vivo investigation 
of these mechanisms by developing novel optical spectroscopy technology for continuous 
monitoring of cerebral oxygen delivery, consumption and metabolism. Because we use 
diffuse optical spectroscopy to perform these measurements non-invasively through the 
skull, our methods and devices have potential for rapid translation to clinical use. 
Cerebral oxygen metabolism and its link to blood flow 
Cerebral metabolism proceeds overwhelming through oxidative metabolism of 
glucose. Under a wide variety of physiological and pathological conditions, cerebral 
metabolism has been found to remain tightly coupled to consumption of the metabolic 
substrates glucose and oxygen (Clarke et al. 1999; McKenna et al. 2012; Gjedde, 2011). 
However, our spectroscopic methods measure neither metabolism nor the consumption of 
these substrates directly. Instead, we rely on the tight coupling between oxygen and 
cerebral metabolism to infer the consumption of oxygen from optical absorption of 
hemoglobin in blood and blood flow from dynamic light scattering on moving red blood 
cells. 
The physiological mechanisms for the transport and storage of glucose and O2 in 
the brain are quite different, leading to profound implications for the regulation of 
cerebral blood flow. O2 passively diffuses across cell membranes, while glucose requires 
active transport across the blood brain barrier (Gjedde et al. 2011). Unlike O2 diffusion, 
transport of glucose is rate-limiting, so the cerebral metabolic rate of glucose (CMRg) is 
largely independent of plasma glucose concentration (Clarke et al. 1999; McKenna et al. 
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2012). Thus glucose delivery does not play a major role in regulating cerebral glucose 
levels, except in extreme cases such as severe hypoglycemia and shock. Intracellular 
stores of glucose are also uniformly maintained at 1-3 mM (about 25% of plasma 
concentration) across all brain regions (McKenna et al. 2012). However, resting CMRg is 
highly variable with region, indicating a very close linkage of glucose supply and 
demand. 
In contrast, there are no intracellular O2 stores in brain so net consumption of O2 
is reflected in the oxygen concentration gradient across the blood brain barrier (McKenna 
et al. 2012). In the resting state, about half of the oxygen in the blood is extracted into 
cerebral tissue, as opposed to only 10 percent of blood glucose (Paulson, 2002; McKenna 
et al. 2012). Thus, while increased demand for glucose can be made up in part by greater 
extraction of it from the blood, the lower extraction reserve for circulating oxygen means 
that increased delivery of oxygen must be associated with increased blood flow. Hence, 
changes in cerebral metabolic demand are more directly reflected in changes in cerebral 
blood flow than in changes of hemoglobin oxygen saturation.  
Metabolic rates can be quantified by the net rate of substrate utilization according 
to the Fick principle (Clarke et al. 1999), by which the conservation of mass requires the 
rate of exchange of a substrate between blood and an organ is equal to the flow blood 
times the arterio-venous difference in substrate concentration: 
𝐶𝐶𝐶𝐶𝐶𝐶 = 𝐶𝐶𝐶𝐶𝐶𝐶 ∗ ([𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠]𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎 − [𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠]𝑣𝑣𝑎𝑎𝑣𝑣𝑜𝑜𝑜𝑜𝑜𝑜)   (Equation 1-1) 
For glucose, this metabolic rate is the CMRg. For oxygen, these are the atererio-venous 
difference in O2 (AVDO2) and cerebral metabolic rate of oxygen (CMRO2). Non-zero 
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arteriovenous differences represent net uptakes or releases of the substrate. However, due 
to the influence of CBF, arteriovenous differences alone do not provide accurate 
quantification of the rate of substrate utilization or production without relying on 
significant assumptions. Since AVDO2 is expressed in units equivalent to mol O2/L and 
CBF has units equivalent to L/min/100 g tissue, CMRO2 has units equivalent to mol 
O2/min/100 g tissue. 
Cerebrovascular reactivity 
Although cerebrovascular reactivity consists of a complex multiplicity of sensing 
and regulatory pathways, its actions always result in a change in blood flow effected by a 
change in vessel diameter mediated by contractile cells (Panerai, 2003; Ainslie et al. 
2009; Willie et al. 2014). This mechanism can be rationalized as having evolved as a 
consequence of Poiseuille’s law, where the resistance to flow, R, is 𝐶𝐶 = 𝜇𝜇𝜇𝜇
𝜋𝜋𝑑𝑑4
, with L being 
the length of the vessel segment and d is the vessel diameter. The flow itself is governed 
by the resistance and the perfusion pressure through the vessel segment according to 
𝐶𝐶 = ∆𝑃𝑃
𝑅𝑅
. The strong dependence of flow on vessel diameter makes regulating the diameter 
a very effective means of regulating flow, though the other factors influencing flow (L, µ, 
∆P) are also mechanistically relevant. The linear dependence of flow resistance on vessel 
length enables the entire vascular tree, from proximal extracranial arteries feeding the 
brain to distal arterioles in the parenchyma, to contribute to the cerebrovascular reactivity 
process through a network of segmental vascular resistances (Cipolla, 2010). Though the 
muscular, proximal conduit arteries make small fractional changes with respect to their 
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diameter, their net effect on flow is still substantial by virtue of their long length (Willie 
et al. 2014). While the relative contribution of the different anatomical compartments 
remains controversial, some estimates have upwards of half of the vascular resistance 
originating in the larger proximal extra- and intra-cranial vessels (Cipolla, 2010). The 
reactivity of these vessels partially buffers global cerebral circulation from fluctuations in 
systemic physiology (Willie et al. 2014). The bulk of the other half of flow resistance 
originates in the pial and parenchymal vasculature. These smaller vessels are less 
muscularized and their thin walls make them capable of great changes in relative 
diameter. Despite their short length, the dependency of flow on the fourth power of 
diameter in Poiseuille’s law magnifies the effect of these small vessels on the regulation 
of flow. These distal vessels of the microcirculation are responsible for regional and local 
regulation of blood flow, and are therefore most strongly associated with neurovascular 
coupling (Cipolla, 2010). However, anatomical-based separation of activity is by no 
means absolute. For example, vessel dilation in response to elevated paCO2 is a specific 
response of the cerebral circulation which is not shared by the peripheral circulation 
(Semb et al. 1984). CO2 reactivity elicits dilation of all motile segments of the cerebral 
vascular tree, from extracranial conduit vessels down to parenchymal microvasculature. 
Dilation of the entire tree enables a global response to changes in systemic physiology 
while maintaining the balance of pressures, and hence relative flows, across the different 
segments of the tree. In contrast, other cerebrovascular reactivity functions such as 
neurovascular coupling are capable of responding to focal changes in brain state through 
actions limited in scope to the local microvasculature around the vicinity of the activity. 
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The complexity of cerebrovascular reactivity pathways reflects the wide range of factors 
influencing cerebral perfusion homeostasis and the tight control of oxygenation required 
for cerebral health and function. 
Cerebrovascular carbon dioxide reactivity (CCO2R) 
Cerebrovascular reactivity towards CO2 is important because it is responsible for 
the largest changes in CBF under physiological conditions (Cipolla, 2010). Hypercapnic 
vasodilation from paCO2 variations within normal ranges can increase cerebral blood 
volume (CBV) by up to a third, with a 3 percent increase in CBF for every mmHg 
increase in CO2 (Dagal, 2009), until the vessel are completely dilated (Figure 1-1). No 
comparable activity is evoked for physiological changes in paO2 (Figure 1-1), so 
although cerebrovascular reactivity is crucial for managing delivery of oxygen, reactivity 
to O2 is surprisingly unimportant, except in extreme hypoxia (Laycock, 1990). CCO2R is 
a robust reflex which, even under extreme pathological conditions, is very rarely 
impaired. In contrast, other cerebrovascular reactivity pathways, such as autoregulation, 
are notoriously fragile and may be quickly lost after the onset of disease, such as after 
traumatic brain injuries or ruptured aneurisms. Since the pathways share the same 
effectors, robustness of the CCO2R demonstrates cerebral vessels retain their motile 
activity so impairment must occur from failures in the upstream regulatory pathways. The 
robustness of CCO2R is of great practical importance for quantitatively testing methods 
of measuring CBF.   
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Figure 1-1 Cartoon of the effects of chemoregulation on cerebral blood flow. (Left) Cerebrovascular reactivity 
towards CO2 dilates cerebral blood vessels causing cerebral blood flow to increase with increasing concentrations of 
PaCO2. CBF ceases to change during extreme hypocapnia and hypercapnia, after further changes in vessel tone are no 
longer possible. (Right) Over physiological ranges of PaO2, CBF remains unaffected. CBF increases only during 
extreme hypoxia. Figures modified from Laycock (Laycock, 1990). 
 
CCO2R vasodilation has one of the few well understood molecular pathways of 
cerebrovascular reactivity (Paulson, 2002). CO2 can freely diffuse across cell membranes 
and the blood brain barrier, but bicarbonate ions cannot pass through them. This barrier to 
bicarbonate prohibits transmission of intravascular pH to the vascular smooth muscle 
cells (vSMCs) and other contractile cells that control vessel tone. Hence CBF is 
independent of intravascular pH, but dissolved CO2 decreases the pH of cerebral spinal 
fluid (CSF) and perivascular extracellular spaces, which activates vSMCs to dilate 
vessels. The vasodilatory effects of CO2 are abolished when the pH of these 
compartments is artificially buffered (Yoon et al. 2012). Surprisingly, pH signals are 
transduced within vSMCs by different pathways in adults and neonates (Brian, 1998). In 
adults, signaling occurs through NO and cGMP while in neonates the signal is mediated 
by prostaglandins and cAMP. Both pathways result in dilation of the vessel from 
contractile motion of the vSMC after the release of intracellular Ca2+. The different signal 
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pathways for adults and neonates may explain observations of elevated CCO2R in infants 
under inhalable general anesthesia (Rowney et al. 2002). 
CCO2R is also important as the historical basis for one of the most fundamental 
concepts in cerebral circulation, the Grubb relationship between cerebral blood flow and 
volume (Grubb et al. 1974). While changing levels of inspired CO2 in ventilated rhesus 
monkeys, Grubb found CBV and CBF, when normalized to their normocapnic values, are 
related by a power law: 
𝐶𝐶𝐵𝐵𝐵𝐵𝐵𝐵𝐵𝐵 𝑉𝑉𝐵𝐵𝐵𝐵𝑠𝑠𝑉𝑉𝑠𝑠 = �𝐶𝐶𝐵𝐵𝐵𝐵𝐵𝐵𝐵𝐵 𝐶𝐶𝐵𝐵𝐵𝐵𝐹𝐹�𝛼𝛼      (Equation 1-2) 
From the fourth order power dependence of flow on vessel diameter in 
Poiseuille’s law and the geometric second order dependence of volume per unit length on 
diameter, basic principles predict α should be 0.5 (Piechnik et al. 2008; Lorthois et al. 
2011; Cornelius et al. 2015). Instead, α is found experimentally to be 0.38, with 
discrepancy between CBF and CBV attributed to complex sources of compliance within 
the vascular network. While the origin of the volume-flow mismatch is still an area of 
active research, measurements of the Grubb exponent are indicators of the state of 
cerebral circulatory function. Although CCO2R is very rarely impaired, the Grubb 
relationship fails during fast dynamic changes (Jones et al. 2002), with disease (Dehaes et 
al. 2013; 2015) or altered physiology (Roche-Labarbe et al. 2009). 
Neurovascular coupling 
Neurovascular coupling regulates cerebral perfusion to meet the highly dynamic 
metabolic demands of brain activity (Attwell et al. 2002; Iadecola, 2004; Buxton et al. 
2014). While matching perfusion to metabolism is one of the primary responsibilities of 
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the circulation in general, the unique physiology of the brain gives rise to a 
correspondingly unique regulatory system of neurovascular coupling (Attwell et al. 
2002). Functional hyperemia, the metabolically-driven hyperemic process in the brain, 
occurs predominately via a feedforward mechanism where neural activity is sensed and 
signaled to vessels in anticipation of metabolic demand rather than a feedback 
mechanism sensing the products of metabolism (Figure 1-2) (Buxton et al. 2014). The 
feedforward mechanism of neurovascular coupling results in a characteristic 
hemodynamic response to functional brain activation, where the oxygen content of blood 
in the region of activation actually increases even though the activated tissue is 
consuming a greater amount of it (Fox et al. 1986). This unexpected increase in blood 
oxygen occurs because the feedforward signals of neurovascular coupling trigger a large 
increase in blood flow that supplies oxygen in vast excess of the metabolic demand from 
the tissue. The increase in blood flow occurs rapidly, beginning with the onset of 
activation and remaining synchronous with the elevated metabolic activity. In 
neurovascular coupling, increases in neuronal activity are signaled via intermediate cells 
such as astrocytes and cause parenchymal and pial vessels to dilate (Attwell et al. 2002). 
The constituent vessels, cell types, and signaling pathways of this process are diverse and 
not well-understood. 
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Figure 1-2 Cartoon of stereotypical of evoked hemodynamic responses to somatosensory stimulation. At time 
zero a stimulation occurs. Prior to the stimulation, blood flow, hemoglobin concentrations, and oxygen metabolism are 
at baseline levels. A large rise in CBF coincides with the onset of evoked neuronal activity. Since the rise in CBF 
supplies oxygen in vast excess of neuronal metabolic need (CMRO2), the oxygen saturation of cerebral blood increases, 
even as the amount of oxygen consumed from the blood by the tissue also increases in absolute terms. CBF and 
CMRO2 return rapidly to baseline with the end of stimulation. Hemoglobin concentrations return to baseline more 
slowly than CBF and metabolism according to the slower hydrodynamic process of clearing the blood volume bolus. 
CBF and CMRO2 models modified from a figure by Buxton (Buxton, 2010). Hemodynamic data modified from a 
figure by Franceschini (Franceschini et al. 2003). 
 
The amount of excess blood flow elicited by brain activation is quantified with 
the flow metabolism coupling ratio, n. The ratio is determined from the peak values of 
regional cerebral blood flow and oxygen metabolism, normalized to their respective 
baselines: 
𝑛𝑛 = |𝑎𝑎𝑟𝑟𝑟𝑟𝑟𝑟−1||𝑎𝑎𝑟𝑟𝑟𝑟𝑅𝑅𝑟𝑟2−1|        (Equation 1-3) 
For normal brain activity, coupling ratios ranging from 2 to 4 are reported in the literature 
(Buxton, 2010), with the average being about 3. Much lower values of the coupling ratio 
can occur during pathological states which cause the blood supply to become mismatched 
with metabolic demand. Depending on circumstances, the mismatch can originate from 
either demand-side or supply-side dysfunction. For example, in conditions such as 
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seizures or cortical spreading depression, pathologically excessive metabolic demand 
exceeds the physiological capacity of the cerebral circulation and the coupling ratio can 
fall to unity (Bruehl et al. 1998). Conversely, conditions leading to hypoperfusion can 
also reduce the coupling ratio when impaired supply is unable to fulfill normal demand. 
In extreme cases, the level of neuronal activity becomes limited by the amount of blood 
flow, putting the brain at high risk for injury. 
The degree of utilization of the oxygen carrying capacity of the blood is 
characterized by the hemoglobin oxygen saturation (SO2) and by a related measure, the 
oxygen extraction fraction (OEF) (Baron et al, 2012; Gjedde, 2006). SO2 is the well-
known expression for the fraction of hemoglobin bound with oxygen:  
𝑆𝑆𝑂𝑂2 = [𝐻𝐻𝐻𝐻𝑟𝑟][𝐻𝐻𝐻𝐻𝑅𝑅]+[𝐻𝐻𝐻𝐻𝑟𝑟]        (Equation 1-4) 
where [HbO] and [HbR] are the concentrations of oxygenated and deoxygenated 
hemoglobin. OEF is a derived measure frequently used in neuroenergetics: 
𝑂𝑂𝑂𝑂𝐶𝐶 =  (𝑆𝑆𝑎𝑎𝑟𝑟2−𝑆𝑆𝑣𝑣𝑟𝑟2)
𝑆𝑆𝑎𝑎𝑟𝑟2
        (Equation 1-5) 
where SaO2 and SvO2 represent saturations of the arterial and venous sides of a vascular 
segment. Depending on the measurement methodology and the region of interest, OEF 
and CMRO2 can be calculated globally, regionally, or locally down to the level of an 
individual vessel. Since SO2 represents the extent of blood oxygenation while OEF is an 
expression of Fick’s principle for extent of oxygen removed from the blood, SO2 and 
OEF are inversely related such that when SO2 is high, OEF is low and vice versa. 
However, since both quantities are normalized, they do not accurately reflect metabolic 
consumption unless blood flow is taken into account by measurement or assumption 
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(Boas et al. 2011). When a region of the brain becomes activated, it’s CMRO2 will 
increase (reflecting the increased metabolic consumption of oxygen), while neurovascular 
coupling ensures the concomitant increase in regional CBF increases blood SO2 (due to 
the excess oxygen carried by excessive flow response) and OEF will decrease (although 
in absolute terms more oxygen is utilized by the tissue from the blood, the relative 
amount is less due to the excessive flow response). 
Cerebral autoregulation 
Cerebral autoregulation is a reflex which buffers cerebral blood flow from 
extracerebral influences on cerebral perfusion pressure (CPP) to protect the brain from 
injuries which would occur from unregulated CBF (Figure 1-3) (Lassen, 1959). CPP is 
the difference between the tissue inflow and outflow blood pressures, which ordinarily 
are the arterial and venous blood pressures. CPP rises and falls in conjunction with 
changes in arterial blood pressure. In the absence of active regulation, flow is 
proportional to CPP in accordance with Poiseuille’s law, potentially allowing fluctuations 
in CPP to result in dangerously excessive or insufficient CBF. Autoregulation reacts to 
changes in CPP with compensatory changes in cerebrovascular resistance (CVR) to 
maintain nearly constant CBF (Paulson, 1990). However, CBF is effectively regulated 
over only a limited range of physiological perfusion pressures and when CPP is outside 
of this range, flow reverts to passively following pressure. Disease states impact 
autoregulation by both directly influencing CPP and by impairing the autoregulation 
mechanism itself. Pathology such as traumatic brain injury or aneurysm often reduces 
and shifts the autoregulatory region such that the brain is at risk for injury at levels of 
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CPP that would normally be safe. Under neurocritical care, autoregulation is the most 
important means of preventing flow related injuries, because autoregulation, as an 
endogenous control process, works continuously and autonomously to counter ongoing 
changes in perfusion pressure. Therapeutic interventions, such as vasopressors, are not 
nearly as effective because they act to modify mean perfusion to bring it within the safety 
zone, but lack feedback regulation and the stability it provides. 
Intracranial pressure 
Unlike the other organs of the body, the tissue pressure of the brain is not coupled 
to atmospheric pressure. Instead, the brain experiences a unique intracranial pressure 
(ICP) determined by the volume of brain tissue, cerebrospinal fluid, and intracerebral 
blood enclosed within a fixed volume confined by the rigid, non-expandable skull: 
𝑉𝑉𝐼𝐼𝑣𝑣𝑎𝑎𝑎𝑎𝑎𝑎𝑡𝑡𝑎𝑎𝑎𝑎𝑣𝑣𝑎𝑎𝑎𝑎𝑎𝑎 = 𝑉𝑉𝑎𝑎𝑎𝑎𝑜𝑜𝑜𝑜𝑜𝑜𝑎𝑎 + 𝑉𝑉𝑟𝑟𝑆𝑆𝑟𝑟 + 𝐶𝐶𝐶𝐶𝑉𝑉     (Equation 1-6) 
Under normal circumstances small increases in the volume of one of these components is 
compensated by reductions in the others to maintain ICP within normal ranges through a 
process known as spatial compensation. Spatial compensation is possible because, in the 
absence of injury or disease, CSF freely flows between the cranial and spinal 
compartments and epidural venous blood is easily expelled from the spinal canal. Thus, 
some amounts of blood or CSF can redistribute as necessary between cranial and extra-
cranial regions of the dural sac (Martins et al. 1972). Furthermore, compensation of the 
total volume of CSF can occur by alteration of the rate of CSF absorption.  
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When spatial compensation is insufficient or compromised, the constituents of the 
craniospinal system have limited capacities for compression under pressure, leading to an 
intracranial volume that is actually partially elastic, rather than fully rigid: 
𝑉𝑉𝐼𝐼𝑣𝑣𝑎𝑎𝑎𝑎𝑎𝑎𝑡𝑡𝑎𝑎𝑎𝑎𝑣𝑣𝑎𝑎𝑎𝑎𝑎𝑎 = 𝑉𝑉𝑎𝑎𝑒𝑒𝑜𝑜𝑎𝑎𝑎𝑎𝑎𝑎𝐻𝐻𝑎𝑎𝑎𝑎𝑜𝑜𝑒𝑒 + 𝑉𝑉𝑎𝑎𝑎𝑎𝑎𝑎𝑜𝑜𝑎𝑎𝑎𝑎𝑡𝑡     (Equation 1-7) 
Where Vequilibrium is the intracranial volume under normal ICP and Velastic is the change in 
volume of the craniospinal system due to changes exceeding accommodation by spatial 
compensation. In infants, deformation of the compliant immature skull allows further 
elasticity. Cerebral compliance is defined by ∆𝑉𝑉
∆𝑃𝑃
 and represents the rigidity of the 
craniospinal compartment and is an indicator of the compensatory reserve for buffering 
changes in volume. Compliance is not constant but decreases with increasing pressure 
and can be impaired by pathology.  
  
Figure 1-3 Clinical zones of cerebral perfusion. The cerebral autoregulation curve was originally measured by 
Lassen (Lassen, 1959). In the optimal zone, autoregulation actions maintain CBF by compensating changes in CPP 
with changes in cerebrovascular resistance (left, circles proportional to CVR).  However, outside the optimal range of 
CPP, vessels lack the capacity for further adaptation and flow follows passively from CPP.  Increases in ICP reduce 
CPP and may result in dangerous ischemia, especially if CCP drops below the lower limit of autoregulation. Risk is 
also increased with higher levels of ICP due to reductions in cerebral compliance with increasing ICP. The optimal 
perfusion zone may be narrowed and shifted by chronic conditions, such as hypertension, or acute pathology, such as 
traumatic brain injury (right). Under these conditions, smaller increases in ICP can result in ischemic risk. Perfusion 
reserve, the difference between a patient’s CPP and the lower limit of autoregulation is a clinical indicator of cerebral 
ischemic risk. Figures modified in part from Lang (Lang, et al. 2005). 
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In pathological conditions, such as traumatic brain injury (TBI), a cascade of 
events including brain swelling, vascular engorgement, obstruction of cerebrospinal fluid, 
edema, and/or intracranial hemorrhage, can exhaust compensatory mechanisms and lead 
to an exponential increase in ICP (Figure 1-3). Elevated ICP can dangerously reduce 
cerebral perfusion pressure and cerebral blood flow, causing ischemic brain injury 
(Figure 1-3). Since cerebral compliance decreases with increasing ICP, similar sized 
volume changes, including pulsatile blood volumes, result in larger changes in pressure. 
The risk is greatest when CPP is driven outside of the range of cerebral autoregulation, 
where cerebral blood flow is uncontrolled and passively follows pressure. Furthermore, 
the autoregulatory region can be reduced and shifted by both chronic and acute 
pathology. For example, in chronic hypertension or sleep apnea, vessels adapt to higher 
pressures or elevated paCO2, shifting basal vessel tone, reducing the range of 
autoregulated cerebral vascular resistance, and raising the CPP ischemic limit. Perfusion 
reserve is the difference between measured CPP and the lower pressure limit of 
autoregulation and is an important clinical indicator for assessing risk of ischemic injury. 
In managing intracerebral hemorrhage, interventions lowering blood pressure may lead to 
undesirable ischemia, while maintaining blood pressure may lead to hyperemia and the 
risk of hematoma expansion. Determining perfusion reserve can help to maintain optimal 
cerebral blood flow, limiting risk and achieving better outcomes. Increased ICP can also 
cause serious injury or death through physical extrusion of brain tissue through rigid 
extra-cerebral features such as the dura mater tentorium or foramen magnum and/or 
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compression of the brain stem. Decreased ICP can cause hemorrhage or even ventricle 
collapse, with greatest risk occurring during interventions such as CSF drainage. 
Because increased ICP is an important cause of secondary brain injury, and its 
degree and duration is associated with poorer outcomes (Stein et al. 2010; Alali et al. 
2013), monitoring of ICP is recommended for the management of a wide range of 
disorders, including traumatic brain injury (TBI), intracerebral and subarachnoid 
hemorrhage, hydrocephalus, benign intracranial hypertension, cerebral edema, stroke, 
meningitis, central nervous system infections, acute liver failure and hepatic 
encephalopathy, etc... Continuous monitoring of ICP to guide the clinical management of 
patients is associated improvement in outcomes.  
Motivation for Developing Diffuse Optical Spectroscopy Techniques for Measuring 
Cerebral Blood Flow, Oxygenation, and Metabolism  
 The phenomena and mechanisms described above remain poorly understood.  For 
this reason, we developed methods to perform relevant measurements in vivo with non-
invasive techniques. Diffuse optical spectroscopy, the spectroscopy of turbid media, uses 
light to reach through the skull to determine physiological properties of the brain from 
measurements performed harmlessly from the surface of the head. Optical absorption 
spectroscopy in the near-infrared region (NIRS), with proper accounting for the 
propagation of light through the highly optically scattering media of tissue, reports the 
state of tissue oxygenation using blood hemoglobin as an endogenous contrast agent. 
Measurements of oxygenation state alone are insufficient to disambiguate changes caused 
by changes in oxygen supply versus changes in cerebral metabolic demand. Diffuse 
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correlation spectroscopy (DCS), an extension of dynamic light scattering (DLS) to turbid 
media, is one of the few methods to measure cerebral blood flow non-invasively. DCS, 
when combined with NIRS, enables determination of the cerebral metabolic rate of 
oxygen. Unlike other methods, NIRS and DCS is performed on the benchtop or at 
bedside and has sufficient temporal resolution to resolve dynamic physiological 
processes. In this thesis, we exploit the advantages of these techniques to perform multi-
modal investigations to correlate dynamic brain activity with cerebral metabolism and 
evaluate cerebral vascular reactivity. We introduced a completely novel method to 
enhance the sensitivity of DCS measurements to the brain and implemented it by creating 
a custom ultrafast optoelectronic instrument. We developed new technology to extend the 
temporal resolution of these methods to measure the pulsatile dynamics of cerebral blood 
flow. We show the variations in blood volume during the cardiac cycle can be used with 
DCS as an endogenous probe of the flow-volume relationship in the cerebral circulation 
with the potential for non-invasive measurement of vascular tone and intracranial 
pressure. The new methods we introduce are readily applicable for human use. 
Optical Absorption Spectroscopy 
 Optical absorption spectroscopy measures the attenuation of light after it travels 
through a medium to infer properties of the constituents of the medium. Absorption of 
light by molecules in clear media is quantified by the transmittance: 
𝐼𝐼𝑎𝑎 = 𝐼𝐼0𝑠𝑠−𝜇𝜇𝑎𝑎𝜇𝜇 (Equation 1-8)  
where I0 is the intensity of the incident light, It is the intensity of light after travels 
through the medium. L is the length of the path the light traveled through the medium. µa 
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is the optical absorption coefficient which quantifies the rate at which light is lost to 
absorption by the medium. µa has units of cm-1.  
The well-known Beer-Lambert law relates optical absorbance to the concentration 
of absorbers. For the case of oxy- and deoxy- hemoglobin, the Beer-Lambert law can be 
expressed as: 
𝑂𝑂𝑂𝑂(𝜆𝜆𝑎𝑎) = (𝜀𝜀𝐻𝐻𝐻𝐻𝑅𝑅(𝜆𝜆𝑎𝑎)[𝐻𝐻𝑠𝑠𝐶𝐶] + 𝜀𝜀𝐻𝐻𝐻𝐻𝑟𝑟(𝜆𝜆𝑎𝑎)[𝐻𝐻𝑠𝑠𝑂𝑂]) ⋅ 𝐿𝐿 (Equation 1-9)  
where OD is the optical density (OD=log(It/I0)), and ε are the extinction coefficients for 
hemoglobin, [HbR] and [HbO] are the concentrations of hemoglobin, and L is the path 
length. If absorption measurements are performed at two or more wavelengths, λi, the 
Beer-Lambert law can be inverted to determine the absolute concentrations of oxy- and 
deoxy- hemoglobin. 
If a medium contains optical scatterers, light will be lost both from absorption by 
the medium and from light scattering in directions away from the detector. Simply 
measuring light attenuation at a single, localized detector cannot distinguish between 
these two types of losses. For a medium with a dilute concentration of optical scatterers, 
photons only scatter once as they travel through the medium to the detector. In this singly 
scattering case, the expression for the transmittance can be extended to include the effect 
of scattering: 
𝐼𝐼𝑎𝑎 = 𝐼𝐼0𝑠𝑠−(𝜇𝜇𝑎𝑎+𝜇𝜇𝑠𝑠)𝜇𝜇 (Equation 1-10)  
where µs is the optical scattering coefficient which is defined for scattering analogously 
as µa is defined for absorption. The units of µs are also cm-1. 
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 The situation is greatly complicated when the concentration of scatters increases 
such that light scatters multiple times through the medium to the detector. In the multiply 
scattering case, the transmittance is affected not only by the µs term, but also from an 
increase in the path length, L, as the scattering events cause the light to take an indirect 
path through the medium to the detector. A simple approximation modifies the Beer-
Lambert law to account for the path length increase and enables quantification of changes 
in absorber concentration from measurements of attenuation (Delpy et al. 1997). For 
hemoglobin, the modified Beer-Lambert becomes: 
( ) ( ) [ ] ( ) [ ]( ) ( )iiHbOiHbRi DPFLHbOHbROD λλελελ ⋅∆+∆=∆  (Equation 1-11)  
where DPF is the differential path length factor, a wavelength dependent correction for 
the effect of scattering on path length. The DPF depends on the distribution of path 
lengths through the medium, which in turn depends on the medium’s scattering 
coefficient. To use the modified Beer-Lambert law, the DPF must be determined 
independently by measurement, theory, or assumption. A limitation of this approach is 
that changes in a medium’s scattering coefficient will cause apparent changes in 
absorbance which cause erroneous changes in the estimated hemoglobin concentrations. 
Near-Infrared Spectroscopy (NIRS) 
 Near-infrared spectroscopy (NIRS) is a form of optical absorbance spectroscopy 
in tissues (Ferrari et al. 2012). NIRS is most often used for measuring the concentration 
and/or oxygen saturation of hemoglobin in the blood of buried tissues. NIRS is so named 
because the measurements are performed using light in the near-infrared spectroscopic 
window of tissue. The spectroscopic windows of tissue are defined by the absorption 
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peaks of water and hemoglobin. The windows lie in the wavelength regions between the 
peaks, where absorption is low and scattering predominates. Under these conditions, light 
can diffuse to depths of centimeters within the tissue. In the near-infrared spectral 
window spanning wavelengths from 650 nm to 950 nm, the absorption spectra of oxy- 
and deoxy- hemoglobin are sufficiently distinct that their concentrations can be 
monitored from absorption at two wavelengths, ideally chosen to span hemoglobin’s 
isosbestic point at 800 nm. NIRS differs from pulse oximetry because NIRS measures an 
average absorption of all the vascular compartments, weighted by blood volume. 
Therefore, NIRS measurements are biased toward the microvasculature and the venous 
compartment. Furthermore, NIRS methods are oriented for measurements of deep tissues. 
 
Figure 1-4 Non-invasive, transcranial near-infrared spectroscopy (NIRS) measurement of the cerebral cortex. 
(Left) A cross section of a 3D Monte Carlo simulation of the sensitivity map of a transcranial NIRS measurement on an 
adult head. The source detector separation is 4 cm. Red colors indicate regions of greater measurement sensitivity. 
Because light has to travel through the scalp and skull to reach the brain, NIRS measures a mixture of cerebral and 
extracerebral signals. The simulation was performed using the MCX Monte Carlo simulation software (Fang et al. 
2009). (Right) The path length distribution of light calculated by the diffusion approximation (Equation 1-15) for a 
transcranial measurement with a source detector separation of 2 cm (Kienle et al. 1997; Patterson et al. 1989). Although 
the light source is separated from the detector by a distance of only a few centimeters, scattering in the tissue causes 
photons to travel orders of magnitude longer through the tissue to reach the detector. 
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NIRS provides non-invasive and continuous measures of the attenuation of light 
propagating through the brain cortex. Cortical hemoglobin can be measured 
transcranially from light sources and detectors separated by several centimeters on the 
scalp (Figure 1-4). For NIRS in adults, sources and detectors are typically separated by 
4 cm, leading to a sensitivity that extends about 2 cm deep inside the tissue over a volume 
of several cm3. Children and small animals have thinner extracranial layers, so smaller 
source detector separation are used and the spatial resolution of the measurement 
increases correspondingly. 
In conventional NIRS, light propagation in the tissue can be approximated with 
diffusion theory, since scattering predominates within the spectroscopic window and the 
distances between light sources and detectors are large in comparison to the transport 
mean free path (Ntziachristos, 2010). When scattering predominates, the mean free path 
in the tissue is defined by the average distance light travels in the medium before a 
scattering event occurs. The mean free path is reciprocally related to the optical scattering 
coefficient: 
𝐵𝐵 = 1
𝜇𝜇𝑠𝑠
 (Equation 1-12)  
Scattering in tissue is further complicated because light does not scatter 
isotropically from the scatterers in tissue. Instead, light predominately scatters in the 
forward direction due to intrinsic properties of tissue scatterers. The amount of 
directionality of the scattering event is quantified by the anisotropy, g, which is the cosine 
of the average scattering angle. Empirically, a typical value of g for cerebral 
measurements is 0.9 (Ntziachristos, 2010). With such high directionality, light continues 
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largely in its initial direction after a single scattering event. To account for this 
directionality, the scattering coefficient µs is replaced with the reduced scattering 
coefficient, µs’: 
𝜇𝜇𝑜𝑜
′ = 𝜇𝜇𝑜𝑜(1 − 𝑔𝑔)  (Equation 1-13)  
where the factor of (1-g) accounts for the average number of scattering events which 
must occur to randomize the direction of the light. The transport mean free path, l*, is 
then defined as: 
𝐵𝐵∗ = 1
𝜇𝜇𝑠𝑠′
 (Equation 1-14) 
which represents the distance light must travel in the medium to achieve a random walk. 
 In this regime, the diffusion approximation predicts the distribution of path 
lengths that light travels through the tissue from source to detector for a transcranial 
measurement using semi-infinite media to approximate the transcranial measurement 
geometry (Kienle et al. 1997; Patterson et al. 1989): 
𝑃𝑃(𝑠𝑠) ∝ 𝑠𝑠−32 �𝑠𝑠−𝑣𝑣𝑟𝑟124𝐷𝐷𝑠𝑠 − 𝑠𝑠−𝑣𝑣𝑟𝑟224𝐷𝐷𝑠𝑠� 𝑠𝑠−𝜇𝜇𝑎𝑎𝑜𝑜  (Equation 1-15)  
where s is the photon path length, D is the photon diffusion coefficient, 
D = 1/(3µa + 3µs’), and the r’s are geometric factors accounting for the source detector 
separation on the boundary of the tissue. The shape of the distribution depends on both 
the absorbance and scattering coefficients of the tissue. The distribution has a 
complicated functional form as a consequence of the geometry of the media boundary 
conditions. 
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Figure 1-4 shows the sensitivity profile of transcranial NIRS measurements in a 
human head. Although the light source is separated from the detector by a distance of 
only a few centimeters, scattering in the tissue causes photons to travel a meter or longer 
through the tissue to reach the detector. Continuous wave NIRS (CW-NIRS) uses steady-
state illumination and estimates changes in hemoglobin concentrations using the modified 
Beer-Lambert law. Time-resolved NIRS techniques (TR-NIRS) distinguish the effects of 
optical absorption and scattering in the tissue by measuring the time duration for light to 
travel through the tissue. TR-NIRS is further classified as time-domain NIRS (TD-NIRS) 
or frequency-domain NIRS (FD-NIRS) depending on whether the methods use pulsed or 
modulated light sources. By measuring both scattering and absorption, TR-NIRS can 
determine absolute concentrations of oxy- and deoxy- hemoglobin in tissues. 
NIRS provides non-invasive and continuous measures of the attenuation of light 
propagating through the brain cortex and estimates cerebral blood volume (CBV) and 
cerebral hemoglobin oxygenation (SO2). However, neither SO2 nor CBV are good 
surrogates of CBF. Hemoglobin oxygenation depends on both perfusion and consumption 
and cannot disentangle changes in flow and oxygen metabolism (Boas and Franceschini 
2011). The use of CBV as a surrogate of CBF is based on the Grubb relationship (Grubb 
et al. 1974), which fails during fast dynamic changes (Jones et al. 2002), with disease 
(Dehaes et al. 2013; 2015) or altered physiology (Roche-Labarbe et al. 2009). NIRS can 
also estimate CBF from manipulations of expired oxygen (Edwards et al. 1988) or 
boluses of injected dyes like indocyanine green (Patel et al. 1998), but these methods are 
more invasive and cannot provide continuous monitoring.  
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Diffuse Correlation Spectroscopy (DCS) 
Measuring blood flow in tissues poses a greater technical challenge than 
measuring hemoglobin saturation. While transcranial measurements of SO2 are common, 
few methods can measure cerebral blood flow non-invasively or without radiation (Table 
1-1). MRI-based methods have limited time resolution and cannot be used at the bedside 
or in the field. Transcranial Doppler ultrasound is portable, but is artifact prone and 
difficult to use continuously. Diffuse correlation spectroscopy (DCS) provides a direct 
and more robust way to measure microvascular blood flow optically (Boas et al. 1995; 
Boas and Yodh 1997).   
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Table 1-1. Methods for measuring cerebral blood flow. 
Methodology Human Resolution Time Scale Repeat Invasive Radiation 
Kety-Schmidt  ✔ hemispheric 15 min ✔ ✔ jugular puncture   
Intravenous 133Xe  ✔ 3-4 cm cortical  3-11 min  ✔ ✔ IV ✔ 
Inhaled 133Xe  ✔ 3-4 cm cortical  3-11 min  ✔  ✔ 
Thermal 
Clearance  ✔ 
<1-2 cm 
cortical  <1 min  ✔ ✔ exposed cortex  
Hydrogen 
Clearance   
<5 mm 
cortical  <1 min  ✔ 
✔ needle 
electrode  
PET ✔ <1 cm, 3D min per section limited ✔ IV ✔ 
Single-photon 
Emission CT ✔ <1 cm, 3D 
min per 
section limited ✔ IV ✔ 
Autoradiography   <5 mm, 3D <1 min   ✔ sacrifice  ✔ 
Microspheres   <1 cm <1 min   ✔ sacrifice  ✔ 
MRI Spin-
labeling ✔ <1 cm, 3D Several min limited   
Laser Doppler 
Flowmetry ✔ 1 mm  <1 sec  ✔ ✔ exposed cortex   
Transcranial 
Doppler 
Ultrasound 
✔ hemispheric  <1 sec ✔   
Diffuse 
Correlation 
Spectroscopy ✔ 1-2 cm cortical <1 sec ✔   
 
Modified from Joshi, 2010.   
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 In DCS, a tissue of interest is illuminated by coherent near-infrared light which 
causes a speckle interference pattern to form after the light multiply scatters though the 
tissue (Figure 1-5). Dynamic scattering of the light by flowing red blood cells causes the 
intensity of the speckle pattern to fluctuate rapidly. These fluctuations are quantified by 
measuring the temporal intensity autocorrelation curve of a single speckle. Typically, the 
distance between the illumination source and the detected speckle is chosen to be a few 
centimeters such that blood flow is measured at depths of centimeters within the tissue. 
The decay of the autocorrelation curve is fit with the solution of the correlation diffusion 
equation to assess an index of blood flow (BFi) in units of cm2/s (Boas and Yodh 1997; 
Durduran and Yodh 2014). Although the units of BFi are not the conventional units of ml 
/ min / 100 g tissue for perfusion, BFi is reliably proportional to absolute flow, as 
demonstrated in simulations and validation studies against “gold standard” 
measurements, such as arterial spin-labeled MRI (Durduran et al. 2010; Yu et al. 2007; 
Carp et al. 2010), fluorescent microspheres (Zhou et al. 2009), bolus tracking time-
domain NIRS (Diop et al. 2011) and phase-encoded velocity mapping MRI (Jain et 
al.2013). DCS essentially measures flow, rather than flow velocity, and gives a greater 
weight to flows in the capillary and small vessel compartments, making it a potentially 
better measure of tissue perfusion than methods such as ultrasound which measure blood 
velocity in large supply vessels. Moreover, unlike laser Doppler flowmetry, which is 
limited to measurement depths of at most a millimeter, the remote source detector 
separation in DCS make it possible in humans to measure blood flow in the cerebral 
cortex from a sensor placed on the scalp. 
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However, transcranial NIRS and DCS methods have their own set of drawbacks. 
Though DCS measures absolute flow, its units are unconventional and lack physiological 
intuition. Determination of absolute flow requires independent measurements of the 
optical properties of the tissue, though these can be conveniently provided by TR-NIRS. 
Comparison of NIRS and DCS values across subjects is valid for infants, but skull 
thickness variations in older children and adults limits comparisons without independent 
radiological measurements of the skull geometry. NIRS and DCS are both subject to 
unwanted signals from blood flow in the scalp, though DCS generally has twice the 
sensitivity of NIRS to cortical signals (Selb et al. 2014). NIRS and DCS are also 
influenced by extracerebral pathological tissue, such as edema and subdural hematoma, 
when they occur in the region of measurement. On balance, DCS has the potential to 
equal or exceed the performance of other non-invasive methods like transcranial Doppler 
ultrasound (TCD) while expanding them to perform continuous monitoring that is 
currently not possible.   
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Figure 1-5. DCS quantitatively relates blood flow to the temporal fluctuations of the intensity of a 
single speckle in the interference pattern generated after high coherence light travels through tissue. 
(Top) DCS, being an interferometric technique, requires illumination by a high coherence light source with 
well-defined electric field phase fronts, E0. As the light travels through the tissue, it will scatter many times 
before reaching the detector. If the coherence length of the illumination light is longer than the distribution 
of path lengths travelled through the tissue, a speckle pattern will result from random constructive and 
destructive interference of photons traveling paths of different lengths. Intensities of individual interference 
speckles are independent, so DCS signal contrast is preserved only over a single speckle. Intensity from 
individual speckles are typically isolated by detecting light from tissue through single mode optical fibers 
with an active diameter of only 5 µm. Observed intensity decorrelation rates of individual speckles are 
related to blood flow in the tissue, with faster blood flows causing faster rates of intensity decorrelation. 
(Middle) Light scattering in the tissue occurs in part from scattering sites which do not move significantly 
relative to the wavelength of light within milliseconds. However, flowing red blood cells do move this 
quickly, and a fraction of light scattering, α, occurs from them. At any given instant, the configuration of 
all the scatterers in the tissue is random and the net superposition of light at the detector results in a random 
intensity. However, regardless of the intensity value, after time periods of hundreds of nanoseconds, the 
detected intensity remains similar to whatever was its previous value since flowing red blood cells have not 
yet had time to move appreciable. After longer time intervals of microsecond durations, flowing red blood 
cells have moved significant distances relative to the wavelength of light, so the intensity of light at the 
detector is now random compared to its previous value. Faster blood flows reconfigure scatterers more 
quickly, yielding faster decorrelation rates. (Bottom) Since the scattering process is random, the time 
sequence of the intensity values cannot be predicted. However, the decorrelation process can be quantified 
in a statistical sense through measurement of intensity autocorrelation functions. The actual rate of 
decorrelation depends on additional factors beyond the rate of blood flow, such as α, the optical properties 
of the tissue, and the distance of separation between the light source and detector. 
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Theoretical Basis of DCS 
The theory of DCS was originally developed by Boas (Boas et al. 1995; Boas and 
Yodh 1997). DCS extends dynamic light scattering (DLS) from the single-scattering limit 
to the multiscattering regime. Selected steps from derivations in Boas (Boas, 1996) are 
briefly summarized here because they are helpful for understanding Chapter 3. 
 
 
Figure 1-6. Light scattering by an ensemble of particles for the theoretical calculation of DCS. (Top) Single 
scattering case. Each photon scatters only once to reach the detector. This would be the case for dilute solutions of 
scatterers. The black dots represent particles which scatter light, which in tissue are red blood cells, organelle, etc... The 
k’s are the photon wave vectors before and after scattering. (Bottom) Multiply scattering case. For media with high 
scatterer concentrations, such as tissues, photons scatter many times before reaching the detector. N is the number of 
times a photon has scattered in the medium. s is the total length the particle has travelled in the media before reaching 
the detector. Figure modified from Boas, 1996. 
Step one: The electric field E at a detector can be written by superposition for 
light arriving at the detector after singly scattering from an ensemble of Np particles 
(Figure 1-6): 
𝑂𝑂 = 𝑂𝑂0𝐶𝐶(𝑞𝑞)𝑠𝑠𝑎𝑎𝒌𝒌𝑜𝑜𝑜𝑜𝑜𝑜⋅𝑹𝑹𝑑𝑑 ∑ 𝑠𝑠−𝑎𝑎𝒒𝒒⋅𝒓𝒓𝑛𝑛𝑁𝑁𝑝𝑝𝑣𝑣=1   (Equation 1-16) 
where E0 is the amplitude of the field of the incident light, F(q) is the scattering form 
factor, k are the photon wave vectors, q is the momentum transferred by the scattering 
event (q = kout – kin), Rd is the position of the detector, and rn is the position of the nth 
particle. 
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Step two: The temporal electric field autocorrelation function can be calculated 
for the field at the detector, assuming the particles move with a mean squared 
displacement of <∆r2(t)>. The symbol <∆r2(t)> represents the mean squared 
displacement in bracket notation. Bracket notation is symbolic shorthand for the 
operation of calculating the average value of a function F(x,t) over space using an 
integral over the probability density function (PDF) for the particles position, P(x,t): 
〈𝐶𝐶(𝑠𝑠)〉 = ∫ 𝐶𝐶(𝑥𝑥, 𝑠𝑠)𝑃𝑃(𝑥𝑥, 𝑠𝑠)𝐵𝐵𝑥𝑥∞−∞  (Equation 1-17) 
The temporal autocorrelation function is defined in bracket notation as: 
〈𝑓𝑓(𝑠𝑠)𝑓𝑓(𝑠𝑠 + 𝜏𝜏)〉 = ∫ 𝑓𝑓(𝑠𝑠)𝑓𝑓(𝑠𝑠 + 𝜏𝜏)𝐵𝐵𝑠𝑠∞−∞  (Equation 1-18) 
The normalized field autocorrelation is then: 
𝑔𝑔1(𝜏𝜏) = ⟨𝐸𝐸(0)𝐸𝐸∗(𝜏𝜏)⟩⟨|𝐸𝐸(0)|2⟩  (Equation 1-19) 
By convention, the lower-case letter ‘g’ in g1(τ) designates the correlation function is 
normalized and the subscript ‘1’ designates the correlation function is taken over the 
electric field. 
 By substituting the electric field at the detector from Equation 1-16 into the 
definition of temporal field autocorrelation function in Equation 1-18, the autocorrelation 
function can be calculated in terms of the mean squared displacement of the particles: 
𝑔𝑔1(𝜏𝜏) = 𝑠𝑠−16𝑒𝑒2�∆𝑎𝑎2(𝜏𝜏)� (Equation 1-20) 
Since q is the difference between the incident and scattered wave vectors and the 
wave vectors are inversely proportional to the wavelength of light, the field 
autocorrelation function in Equation 1-20 decays with rate determined by the time 
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particles take to move by a distance of a wavelength of light. Faster movement of the 
scattering particles will cause the autocorrelation function to decay faster. 
Step three: The result for the single scattering case can be extended for multiple 
scattering by accumulating the scattering events as the photon travels through the 
medium from the source to the detector: 
𝑔𝑔1
(𝑁𝑁)(𝜏𝜏) = �𝑠𝑠𝑎𝑎 ∑ 𝒒𝒒𝑛𝑛⋅∆𝒓𝒓𝑛𝑛𝑁𝑁𝑛𝑛=1 �
𝑒𝑒, ∆𝑎𝑎 (Equation 1-21) 
where N represents the number of scattering events along the photon path. 
After computing the average in Equation 1-21, the decay rate for the multiply 
scattering case is equal to the decay rate for the singly scattering case multiplied by 
average number of photon random walk steps taken through the medium (s/l*): 
𝑔𝑔1
(𝑁𝑁)(𝜏𝜏) = 𝑠𝑠−13𝑘𝑘02�∆𝑎𝑎2(𝜏𝜏)� 𝑠𝑠𝑙𝑙∗ ≡ 𝑔𝑔1𝑜𝑜(𝜏𝜏, 𝑠𝑠) (Equation 1-22) 
Where s is the total path length the photon takes through the medium and l* is the 
transport mean free path for the photon in the medium. We define this result to be 
g1s(τ,s), the path length dependent field autocorrelation function. 
 Importantly, while decay rate of autocorrelation function in the singly scattering 
case depends only on the mean squared displacement of the particles, the multiply 
scattering case has introduced a dependency on the optical scattering properties of the 
medium through l*. However, g1s(τ,s) does not depend on the optical absorption 
properties of the medium. 
For measuring blood flow in tissue, DCS uses the Brownian diffusion PDF as a 
model for mean squared displacement of red blood cells (Boas et al. 2016): 
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⟨∆𝑠𝑠2(𝜏𝜏)⟩ = 6𝑂𝑂𝑟𝑟𝜏𝜏 (Equation 1-23) 
where DB is the Brownian diffusion coefficient. After substitution of the Brownian mean 
squared displacement and introducing the quantity α, g1s(τ,s) can be put in terms of the 
blood flow index (BFi, in units of cm2/s), αDB: 
𝑔𝑔1𝑜𝑜(𝜏𝜏, 𝑠𝑠) = 𝑠𝑠−2𝑘𝑘02𝜇𝜇𝑠𝑠′𝛼𝛼𝐷𝐷𝐵𝐵𝑜𝑜𝜏𝜏 (Equation 1-24) 
α is the fraction scattering events which occurred from moving scatterers, as opposed to 
stationary ones. The distinction between moving and stationary scatterers is determined 
by the time for scatterers to move significantly with respect to a distance corresponding 
to a wavelength of light. In vivo, red blood cells are the dominant moving scatterers and 
they completely decorrelate the light before slower scatterers can contribute to the 
autocorrelation decay. In general, α is not resolvable independently, so the product of it 
and DB is determined from the correlation curve as the BFi value. Since DB represents a 
velocity-like quantity and α represents a concentration-like quantity, BFi behaves as a 
flow-like quantity, as predicted theoretically (Boas et al. 2016) and confirmed in the 
validation studies cited in the previous section. 
 Step four: Conventional CW DCS receives photons without regard to the path 
they took through the medium. Using the path length distribution P(s), the field 
autocorrelation function for CW DCS can be calculated by integrating over all photon 
paths through the medium:  
𝑔𝑔1(𝜏𝜏) = � 𝑃𝑃(𝑠𝑠)∞
0
𝑔𝑔1𝑜𝑜(𝜏𝜏, 𝑠𝑠)𝐵𝐵𝑠𝑠 
𝑔𝑔1(𝜏𝜏) = ∫ 𝑃𝑃(𝑠𝑠)∞0 𝑠𝑠−2𝑘𝑘02𝜇𝜇𝑠𝑠′𝛼𝛼𝐷𝐷𝐵𝐵𝑜𝑜𝜏𝜏𝐵𝐵𝑠𝑠 (Equation 1-25) 
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P(s) is known from light transport theory using appropriate boundary conditions. For 
transcranial measurements, the diffusion approximation for the distribution, as shown in 
Equation 1-15, leads to: 
𝑔𝑔1(𝜏𝜏) = 𝑔𝑔1(0)−1 �𝑠𝑠−�6𝑘𝑘02𝜇𝜇𝑠𝑠′2𝛼𝛼𝐷𝐷𝐵𝐵𝜏𝜏+3𝜇𝜇𝑎𝑎𝜇𝜇𝑠𝑠′𝑎𝑎1 − 𝑠𝑠−�6𝑘𝑘02𝜇𝜇𝑠𝑠′2𝛼𝛼𝐷𝐷𝐵𝐵𝜏𝜏+3𝜇𝜇𝑎𝑎𝜇𝜇𝑠𝑠′𝑎𝑎2� (Equation 1-26) 
with g1(0) being a trivial normalization constant. 
In this step, integration over the path length distribution has introduced a 
dependency of the autocorrelation curve on the optical absorption properties of the 
medium, µa. Furthermore, the functional form of g1(τ) is more complicated than the 
single exponential decay of the path length dependent autocorrelation function, g1s(τ,s) 
because of the boundary condition effects on the path length distribution.  
Step five: The theoretical treatment is performed by superposition of electric 
fields. However, physical devices measure light intensities, which are the time averaged 
squares of the field. In the final step, the field autocorrelation function is transformed by 
the Siegert relation into an autocorrelation of light intensity:  
𝑔𝑔2(𝜏𝜏) = 1 + 𝛽𝛽|𝑔𝑔1(𝜏𝜏)|2 (Equation 1-27) 
where the subscript ‘2’ in g2(τ) designates the correlation function is taken over the light 
intensity. β is correlation factor which relates the coherence of the source and detector to 
the amplitude of the correlation decay. Conditions which maintain a high degree of 
coherence with respect to the path length distribution will maximize the value of β 
towards unity and increase the correlation amplitude. Conversely, decoherence by factors 
other than dynamic scattering in the medium will reduce β towards zero and diminish the 
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correlation amplitude. In blood flow measurements, large correlation amplitudes are 
desirable because larger amplitudes improve the accuracy of BFi determination. 
Summary 
This thesis develops novel optical spectroscopy technology for continuous 
measurement of cerebral oxygen delivery, consumption and metabolism. These 
innovations were used to investigate cerebral metabolism and cerebrovascular reactivity 
under different states of anesthesia and during models of pathological states with an eye 
toward translating them to clinical use. 
In Chapter 2, a multimodal combination of EEG, NIRS and DCS was developed 
to quantify the coupling between cerebral electrical activity and oxygen metabolism 
during anesthesia-induced burst suppression to help distinguish between proposed 
mechanisms for this brain state. 
Chapter 3 introduces a novel method, time-domain diffuse correlation 
spectroscopy (TD-DCS), for simultaneously measuring photon times of flight and 
correlation in deep tissue. A new device was designed and constructed to measure g1s(τ,s) 
rather than the conventional g2(τ). We exploit these new capabilities to improve the 
sensitivity of transcranial DCS measurements to the brain. 
Chapter 4 suggests the feasibility of using DCS to measure pulsatile cerebral 
blood flow to determine the critical closing pressure of the cerebral circulation for non-
invasively estimating ICP. 
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CHAPTER TWO: Neuro-Metabolic-Vascular Coupling During Anesthesia-Induced 
Bursts Suppression in Rats 
Introduction 
Burst suppression is a brain state operationally defined by a spontaneous, global 
electroencephalography (EEG) activity consisting of quasi-periodic intervals of activity 
and quiescence (Swank and Watson 1949; Brenner 1985). This state arises naturally in 
pathological conditions such as hypothermia (Marion et al. 1997) and coma (Young 
2000) or can be induced by deep levels of general anesthesia (Brown et al. 2010). Burst 
suppression is a unique brain state that is distinct from other types of EEG activities such 
as sleep spindles, cortical spreading depression (CSD), or ictal or interictal epileptiform 
discharges. Burst suppression was first identified during the 1930’s in early experimental 
EEG studies (Derbyshire et al. 1936). Since then, it has since been characterized by 
electroencephalography (Brenner 1985). Burst suppression is recognized in EEG 
recordings as bursts of electrical activity interspersed with isoelectric periods of no 
electrical discharges (Hirsch et al. 2013). The periods occur spontaneously and 
quasiperiodically  (Bauer and Niedermeyer 1979), with the duration of either type of 
period lasting between a half second and 60 seconds depending on physiological 
conditions (Vijn and Sneyd 1998). During a burst, the amplitude and frequency content 
of the electrical activity is identical to the EEG activity that had been occurring in the 
brain prior to entering the burst suppressed state (Ching et al. 2012). Burst suppression 
has thus been likened to a series of sharp digital transitions between an active and 
inactive brain. 
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Burst suppression is important clinically because of its prevalence in anesthesia 
care and its association with worse outcomes when it arises spontaneously in pathological 
conditions (Urrego et al. 2014). Burst suppression is believed to be beneficial when it is 
used to induce a medical coma, but is believed to be harmful when it occurs during 
general anesthesia. Furthermore, the elderly are more prone to enter burst suppression 
than the general population (Purdon et al. 2015), which put these vulnerable patients at 
risk. Despite its importance, the underlying mechanisms which initiate and sustain burst 
suppression are not known, nor are its potential benefits or harms well understood. 
Leading theories propose metabolic (Ching et al. 2012) or ionic (Kroeger and Amzica 
2007) explanations for the burst suppression phenomenon. Despite wide-ranging 
investigations into the electrophysiology of burst suppression, far fewer studies have 
investigated the corresponding cerebral metabolic and physiological activities during 
burst suppression. Understanding these processes is essential to evaluate the proposed 
mechanistic theories and to determine whether burst suppression is beneficial, harmful, or 
merely epiphenomenonolgical. 
While EEG patterns of burst suppression are well known, the underlying cerebral 
metabolism during burst suppression has been less investigated but has been implicated 
in the mechanism driving neuronal activity (Ching et al. 2012). Cerebral oxygen 
metabolism determined from bolus intravenous 133Xe measurement of whole brain CBF 
finds mean metabolism is reduced in the burst suppressed state (Woodcock et al. 1987). 
However, this approach has insufficient temporal resolution to resolve differences in 
metabolism of bursts versus suppression. Dynamic changes in cerebral blood flow (CBF) 
  
38 
during burst suppression had been observed by laser Doppler flow in animals (Golanov et 
al. 1994) and by transcranial Doppler ultrasound in humans (van Alfen et al. 2011). 
BOLD activation during epochs of burst suppression has been observed by fMRI 
(Vincent et al. 2007) to extend across the brain (Liu et al. 2011). Human intracranial 
electrocorticography finds burst suppression activity is widespread over the brain but is 
not homogenous (Lewis et al. 2013). A biophysical computational model proposed by 
Ching (Ching et al. 2012) attempts to link metabolic patterns with the origins of burst 
suppression. However, the temporal evolution of cerebral oxygen metabolism during 
burst suppression under different states of anesthesia has not previously been investigated 
experimentally. 
In this study, we characterize the metabolic and hemodynamic consequences of 
burst suppression induced by general anesthesia. We made simultaneous, real-time 
measurements of both EEG and cortical hemodynamics in rats to investigate the coupling 
between cerebral oxygen metabolism and neuronal activity in the burst suppressed state. 
In particular, we used two non-invasive diffuse optical modalities, near-infrared 
spectroscopy (NIRS) and diffuse correlation spectroscopy (DCS) to measure hemoglobin 
concentration and blood flow continuously in a way that can be rapidly translated to 
human use. We determine the cortical oxygen metabolism and hemodynamic response to 
bursts is similar to the physiological process of functional activation without the 
metabolic and hemodynamic derangements common to other electrophysiological 
pathologies. We find these responses to be a consequence of bursts, rather than a driver 
of brain activity. 
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Methods 
Animal preparation and measurement protocol 
Ten female Sprague–Dawley (295 ± 21 g) were included in this study. During the 
surgical procedures, the animals were anesthetized with isoflurane (2–2.5% v/v) 
administered via a facemask in a gas mixture of 80% air and 20% oxygen. After 
tracheotomy and cannulation of the femoral artery and vein, animals were moved to a 
stereotactic frame, and mechanically ventilated with 100% O2 mixed with varying 
isoflurane concentrations using an anesthesia vaporizer and flowmeter (SurgiVet Isotec 
Vaporizer, Smiths Medical, Dublin, OH). For two animals, CO2 was added to the mixture 
for a hypercapnic challenge. A heating pad was used to maintain the animal’s core 
temperature at 36.5–37.5 °C. 
In three animals, the scalp was surgically removed and EEG activity was recorded 
from screw electrodes implanted in the skull. In these animals, for the diffuse optical 
measurements, optical fibers were placed in a direct contact with the skull. The remaining 
seven animals were prepared minimal invasively, with a single set of subcutaneous 
electrodes for EEG recordings and optical fibers pressed against the skin for NIRS and 
DCS recordings. 
During EEG and diffuse optical measurements, isoflurane was alternated from 1% 
to 2-2.3%, with a 40-minute equilibration period at the different concentrations to allow 
the non-metabolic vasodilatory effects of isoflurane to stabilize. Attention was taken to 
keep the animal in the dark and limit external stimulation because we found stimulation 
evokes non-spontaneous bursts. 
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Normal physiology was verified by blood gas analysis for pO2, pCO2, and pH at 
regular intervals. For most animals, a capnometer (MicroCapnograph 7801C, Columbus 
Instruments, Columbus, OH) was used to record instantaneous expired CO2 levels 
simultaneously with EEG and optical signals. Body temperature, arterial blood pressure, 
arterial oxygen saturation (SpO2), heart rate and ventilation pressure were all 
simultaneously recorded with the NIRS-DCS and EEG data. Table 2-1 shows the 
systemic physiological parameters measured at the two anesthesia levels. All procedures 
were approved by the Massachusetts General Hospital Subcommittee on Research 
Animal Care. 
Table 2-1. Physiological parameters of the measurement groups.  1% v/v Isoflurane 2% v/v isoflurane pO2 (mmHg) 374.9 ± 33.7 384.0 ± 14.6 pCO2 (mmHg) * 36.3 ± 2.8 42.1 ± 2.3 pH * 7.416 ± 0.020 7.393 ± 0.022 etCO2 (mmHg) * 32.7 ± 1.9 38.9 ± 3.0 MABP (mmHg) 106 ± 14 99 ± 9 Heart rate (Hz) 333 ± 18 335 ± 22 Respiration rate (Hz) * 51.7 ± 0.6 50.5 ± 0.7 Burst Suppression Ratio * 0.04 ± 0.2 0.82 ± 0.6 
* significant at p < 0.05 
Electrophysiological recordings  
EEG recordings were performed with the ADS1298 8-channel, 24-bit analog to 
digital converter (ADC) from Texas Instruments. The absence of high-pass and notch 
filters improved signal fidelity. In three animals, EEG signals were acquired from custom 
1 mm diameter stainless steel screws with commercial silver plating. The tips of the 
screws were electrochemically converted to AgCl immediately before implantation 
around the optical probe. In the remaining seven animals, Ag/AgCl disk-type EEG 
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electrodes (4-mm diameter, Warner Instruments, Hamden CT, USA) were implanted 
subcutaneously around the optical probe. Additional electrodes were implanted as 
follows: a reference electrode was positioned posteriorly on the skull, a ground electrode 
was placed in the neck, and two electrodes were placed on the left and right sides of the 
torso for ECG. The EEG and ECG measurements were acquired at a sampling frequency 
of 1 kHz. 
The EEG data were processed off-line using software designed in-house and 
implemented in the MATLAB environment (Mathworks Inc., Natick, MA). Specifically, 
for each animal, the EEG data were high-pass filtered at a −3 dB cutoff frequency of 3.5 
Hz. A notch filter was applied to suppress 60 Hz interference and the ECG signal was 
used to reduce the arterial pulsation with a linear regression model. 
Diffuse optics hemodynamic measurements 
Changes in cerebral hemoglobin concentrations were measured with a 
continuous-wave near-infrared spectroscopy (NIRS) system (CW6, TechEn Inc., Milford, 
MA). NIRS quantifies local cortical hemodynamic changes spectroscopically by 
measuring light absorbance changes at different wavelengths. The CW6 NIRS system 
uses multiple frequency-encoded laser sources to illuminate the tissue and acquires their 
signals in parallel with several avalanche photodiode detectors (Joseph et al. 2006). 
Typical acquisition rate was set to 50 Hz. Sixteen sources pairs (emitting at 690 nm and 
830 nm) and thirty-two detectors are available on the instrument. For experiments in two 
animals (two of the three with removed scalp) we used two sources and eight detectors 
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(Figure 2-1a), and in the remaining eight animals we used one source and one detector 
(Figure 2-1b).  
To obtain hemoglobin concentration changes the NIRS raw data oxy- and deoxy-
hemoglobin concentrations (HbO and HbR, respectively) were calculated using the 
modified Beer–Lambert law(Delpy et al. 1988) assuming a path-length at 690 nm and at 
830 nm calculated from diffusion theory with reduced scattering coefficients assumed to 
be 4 and 5 cm-1, respectively. To obtain relative changes in HbO and HbR we assumed a 
baseline total hemoglobin concentration (HbT) of 120 μM (Watabe et al. 2013) and a 
65% hemoglobin oxygenation (SO2). Using these baseline values, we also estimated the 
changes in SO2 and in the oxygen extraction fraction (OEF) which was used to estimate 
changes in CMRO2. 
In eight animals, cerebral blood flow changes were measured with a home-built 
diffuse correlation spectroscopy (DCS) system. DCS measures microvascular blood flow 
in cortical tissue by quantifying the temporal intensity fluctuations of multiply scattered 
light that arises from moving red blood cells (Boas and Yodh 1997). DCS is similar to 
laser Doppler blood flowmetry (i.e., they are Fourier Transform analogs), but light 
transmission through thick tissue results in low light levels that require photon-counting 
detection techniques. Therefore, DCS measures an autocorrelation function of the 
intensity fluctuations rather than a power spectrum. Numerous validation studies in 
humans and in animals have shown that relative changes and absolute values of CBFi 
agree very well with CBF values measured with “gold standard” methods, such as arterial 
spin-labeled MRI (Carp et al. 2010), bolus tracking time-domain NIRS (Diop et al. 2012) 
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and phase-encoded velocity mapping MRI (Jain et al. 2013). For these measurements, we 
used a solid-state long coherence length laser at 785 nm for illumination (DL852-120-
SO, CrystaLaser, Reno, NV) and four photon-counting avalanche photodiode for 
detection (SPCM-AQRH-14-FC, Excelitas Technologies Corp., Quebec, Canada) (Lin et 
al. 2013). DCS source and detectors fibers were arranged in the probe as shown in Figure 
2-1b on the lateral-most portions of opposite hemisphere with respect to the NIRS fibers 
to avoid optical cross-talk between the DCS and NIRS instruments. Intensity 
autocorrelation functions were determined by a digital correlator at 5 Hz and the cerebral 
blood flow index (CBFi) were determined by fitting the autocorrelation functions to a 
model of dynamic light scattering in deep tissues (Boas and Yodh 1997).  The reduced 
scattering coefficient of the tissue at the DCS wavelength was assumed to be 4.5 cm-1 and 
the absorption coefficient was assumed to be 0.086 based on the absorption of 
hemoglobin at the concentrations assumed for NIRS. Custom software was written for 
Microsoft Windows in C# and C++ to acquire the data continuously, perform the fits in 
real time, and display the results as a vital sign. 
Evaluation of cerebrovascular reactivity towards CO2 
The cerebrovascular reactivity towards CO2 was determined from observations of 
CBFi while levels of end tidal CO2 (etCO2) fluctuated normally during mechanical 
ventilation or when they were explicitly manipulated by the introduction of inspired CO2 
for a hypercapnic challenge. For the challenge, the fraction of inspired CO2 was raised to 
1.5% until the capnometer reached approximate 50 mmHg, at which point the inspired 
CO2 was discontinued. The relationship between CBFi and etCO2 was evaluated by post-
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processing the recorded data. Since bursts did not occur under 1% isoflurane, CBFi 
values for this condition could be directly compared to etCO2 levels. However, under 2% 
isoflurane, values were segmented into separate groups for bursts and for suppression. 
Each etCO2 and non-burst CBFi value was determined from a 10 second average of the 
measured data. Suppressed values were only calculated for regions where CBFi had 
returned to baseline. Since the duration of the hemodynamic response is long, a greater 
number of points could be determined for bursts than for suppression. For the burst 
group, the peak CBFi value during the burst was used instead of an average value. 
Neurovascular coupling analysis 
To obtain the impulse response functions of cerebral hemoglobin concentration 
and blood flow changes (HRF) in response to bursts, the data were deconvolved the burst 
onsets either with or without consideration of burst duration. Burst onset and duration 
where manually determined from the EEG traces during either transition from/to 1 to 2% 
isoflurane, or during the 2% isoflurane periods.  
To determine the HRF we used a linear convolution model between the measured 
hemoglobin time series and the bursts time series described in (Franceschini et al. 2008). 
Briefly, linear convolution modelling was performed using the general linear model 
(GLM) (Gagnon et al. 2011; Friston et al. 1995): 
ℎ(𝑠𝑠) = ℎ𝑠𝑠𝑓𝑓(𝑠𝑠) ⊗ 𝑠𝑠(𝑠𝑠)  (Equation 2-1) 
where ℎ(𝑠𝑠) is the measured hemodynamic data, ℎ𝑠𝑠𝑓𝑓 is the unknown impulse 
hemodynamic response function to be determined and s is the record of burst events 
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segmented from the EEG data. All vectors are discretely sampled at 200 ms intervals to 
match the DCS sampling rate. ℎ𝑠𝑠𝑓𝑓 consists of a set of Gaussian temporal basis functions: 
ℎ𝑠𝑠𝑓𝑓(𝑠𝑠) = ∑ 𝐹𝐹𝑎𝑎𝑁𝑁𝑤𝑤𝑎𝑎=1 𝑠𝑠𝑎𝑎(𝑠𝑠) (Equation 2-2) 
where 𝑠𝑠𝑖𝑖(𝑠𝑠) are normalized Gaussian functions with a standard deviation of 1 second and 
their means separated by their standard deviation to span the range of ℎ𝑠𝑠𝑓𝑓. The range of 
ℎ𝑠𝑠𝑓𝑓 was set from -2 seconds to 14 seconds to cover the temporal extent of physiological 
hemodynamic impulse responses. Nw is the number of basis functions are required to span 
ℎ𝑠𝑠𝑓𝑓, which is 15 under these conditions. The wi’s are the weights of the basis function 
and are to be determined by linear least square regression of the ℎ(𝑠𝑠) data. For the burst 
duration model, s has values of 1 during intervals of EEG burst activity and 0 during 
suppression. For the burst onset model, s has values of 1 during the first interval of an 
EEG burst and is zero otherwise. 
Linear least square regression was performed by constructing the design matrix X 
with columns consisting of the linear convolution of the burst event vector s[n] with each 
temporal basis function bi[n] over the discrete sample n at time t: 
𝐗𝐗 = �𝑠𝑠 ⊗ 𝑠𝑠𝑎𝑎[𝑛𝑛] ⋯  𝑠𝑠 ⊗ 𝑠𝑠𝑁𝑁𝑤𝑤[𝑛𝑛]� (Equation 2-3) 
The vector w contains the weights of the temporal basis functions: 
𝐰𝐰 = � 𝐹𝐹1⋮
𝐹𝐹𝑁𝑁𝑤𝑤
� (Equation 2-4) 
The estimates of the weights 𝐰𝐰�  are determined from the data by the ordinary least squares 
solution: 
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𝐰𝐰� = �𝐗𝐗T𝐗𝐗�−1𝐗𝐗T𝐡𝐡 (Equation 2-5) 
The impulse hemodynamic response function is recovered from the estimate of 𝐰𝐰�  and 
Equation 2-2. 
We estimate separate impulse response functions for HbO, HbR and CBF. The 
goodness-of-fit was estimated by calculating the correlation coefficient, R. To determine 
whether onset or duration of burst better fitted the data we used the Fisher's Z 
transformation. 
By combining the NIRS and DCS data we estimated the cerebral metabolic rate of 
oxygen (CMRO2) changes from relative changes on SO2 and CBF, assuming a 100% 
SaO2. The bounds of uncertainty in rCMRO2 were estimated by varying the baseline HbT 
from 80 μM to 170 μM and the baseline SO2 from 55% to 75% to cover the extreme 
physiological limits of these parameters.   
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Figure 2-1. Schematic of optode and electrode locations on the rat head. (a) EEG and NIRS probes were co-
localized to measure the spatial and temporal variation of burst responses. EEG electrodes were placed bilaterally as 
shown to measure brain activity near the forepaw and whisker regions of the somatosensory cortex. NIRS sensors 
consisted of a single source and four associated detectors. Two sets of sensors were placed bilaterally to record changes 
in local cerebral hemoglobin concentrations in the vicinity of the EEG electrodes. The dashed lines indicate the regions 
between optical sources and detectors which were interrogated by spectroscopy measurements. Two regions were 
chosen to coincide the brain areas covered by the EEG electrodes. Two additional medial locations were also probed 
with NIRS. (b) EEG, NIRS, and DCS blood flow measurements were performed simultaneously to determine 
metabolic responses. The sensors were physically separated to facilitate placement on the head while minimizing 
crosstalk between the two optical measurement modalities. Although the measurements were performed at different 
locations on the head, since the burst response is nearly uniform across the cortex, the signals could be analyzed 
collectively, regardless of their region of origin. 
 
Results 
Characterization of the hemodynamics of anesthesia-induced burst suppression 
In two animals, we acquired NIRS and EEG data in several locations in both 
hemispheres (Figure 2-1a) to verify bursts are homogeneously distributed across the rat's 
cerebral cortex. Figure 2-2 show HbO, HbR and EEG temporal changes during a 
transition from 1 to 2 percent isoflurane (0.75 to 1.5 MAC for rats (White et al. 1974)) in 
left and right whisker and forepaw areas. At low isoflurane concentrations (1 percent) the 
EEG shows high and continuous activity and the hemodynamic responses show small 
fluctuations (Figure 2-2 left panels). During transition from 1% to 2% isoflurane (Figure 
2-2 middle panels) EEG activity starts to show periods of suppression and the 
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hemodynamic fluctuations synchronize with the EEG bursts in all measured locations. As 
the anesthetic effects reach equilibrium, a clear burst suppression pattern is observed in 
the EEG traces and to each burst correspond well-defined HbO and HbR changes (Figure 
2-2 right panels). We verified that these patterns of EEG and hemodynamic activity are 
reversible with isoflurane dose and relatively homogeneous across the left and right 
sensory cortices. We calculated differences between the hemoglobin time-traces in the 
left and right whisker and forepaw locations and found correlation coefficients of 0.80 for 
HbO and HbR amplitudes, 0.99 for onsets and 0.99 for latencies.  
 
Figure 2-2. Simultaneous measurement of EEG activity and hemodynamic responses in different cortical regions 
during the transition to anesthesia-induced burst suppression. At time zero, the fraction of inspired isoflurane was 
increased from 1% to 2%. Recordings are shown from two sets of bilateral locations, as indicated. The gray traces are 
EEG activity and the red and blue traces are changes in regional cortical oxy- and deoxy- hemoglobin concentrations, 
respectively. The two large gaps in the EEG traces are when the recording was paused to save data. The transition from 
minimally active to burst suppressed EEG occurs over the course of several hundred seconds as the increase in the dose 
of anesthesia takes effect. As EEG activity becomes more burst-like, electrical activity causes pronounced transient 
increases in oxyhemoglobin and decreases in deoxyhemoglobin concentrations. During burst suppression, each burst 
results in a corresponding hemodynamic response. Furthermore, bursts and responses are nearly synchronous and 
uniform throughout the measured brain regions. 
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Determination of the cerebral hemodynamic, blood flow, and oxygen metabolism impulse 
response functions to an EEG burst 
Once we verified the spatial homogeneity of the bursts we moved the probe 
geometry as shown in Figure 1-1b which allowed us to measure relative changes CBF 
from DCS in addition to measuring changes in HbO and HbRby NIRS. We first acquired 
data in this configuration for one rat (rat # 3) using screw electrodes and optical fibers in 
direct contact with the skull. For the remaining animals (rats # 4-10), we used 
subcutaneous electrodes and pressed the optical fibers onto the surface of the skin. This 
latter procedure is less invasive, faster to prepare, and preserves skull integrity. 
For each animal and each 2% isoflurane run, the EEG burst were manually 
selected and the hemodynamic fits were done to determine the hemodynamic response 
functions (HRF). The data were deconvolved with two different models, a model that 
considered only the onsets of the bursts and another model which considered both the 
onset and duration of the bursts. Figure 2-3 shows an example of HbO, HbR and CBF fits 
over a five-minute run for both deconvolution models. On average 80±20 burst per 
animal were considered for a total of 644 bursts. The average burst duration was 1.4±0.1 
s and the impulse response functions we reported in the following figures are with respect 
a fixed 0.2 s burst period. To obtain hemodynamic responses for a burst of finite duration, 
a linear superposition of the impulse HRF must be performed over duration the EEG 
burst. Because bursts have different durations we just report the deconvolved impulse 
HRF. 
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Figure 2-3. Example of deconvolution fits of the hemodynamic response to EEG activity during burst 
suppression. The top panel shows the results of two different models for fitting the hemoglobin levels to recordings of 
spontaneous EEG bursts. The bottom panel shows similar fits for CBF during the same epoch. In both panels, the solid 
lines are the measured data. The dotted lines are the results of the deconvolution fit when only the onset time of the 
EEG burst is considered in the model. The dashed lines are fits from the model that accounts for both the onset time 
and duration of the electrical burst. Incorporating the burst duration into the model produced fits with significantly 
better correlation to the data. Thus, longer electrical bursts produce larger hemodynamic responses. 
 
Considering burst duration produced better fits than considering burst onsets, 
because longer burst caused larger hemodynamic responses. The average correlation 
coefficients of the fits considering burst duration and burst onset are reported in Table 2-
2. Statistical significant differences were assessed with the Student's t-distribution and p-
values of ~0.01 were found for all hemodynamic parameters.    
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Table 2-2. Average correlation coefficient (R) for fits to the two different deconvolution models. 
 
 
 
 
*Data presented as average over 8 animals and standard errors 
 
Because the correlation was higher for the model which includes burst duration, it 
was used for all the following calculations. The hemoglobin and CMRO2 response 
functions for each animal and the average across eight animals are reported in Figures 2-4 
and 2-5.  
 
Figure 2-4. Hemodynamic impulse response functions determined by deconvolution fitting with the duration-
dependent model. Each line in the graph shows the recovered response function for an individual animal, color coded 
by animal. The left panel shows response functions for oxyhemoglobin (upward going) and deoxyhemoglobin 
(downward going) concentrations. The center and right panels are the recovered CBF and oxygen metabolism response 
functions, respectively. 
  
 Model 
R Burst 
Duration 
Burst Onset 
HbO 0.88 ± 0.02 0.83 ± 0.03 
HbR 0.90 ± 0.02 0.86 ± 0.03 
CBF 0.75 ± 0.03 0.69 ± 0.02 
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Figure 2-5. Group averages of the recovered hemodynamic impulse response functions. The recovered impulse 
response functions are small in magnitude because they represent the response to an infinitesimal period of burst 
activity (approximated by 200 ms). The magnitude of a hemodynamic response to a physical burst is much larger than 
the magnitude of the infinitesimal response because the physical hemodynamic response for a burst arises from the 
additive convolution of many infinitesimal responses over the duration of the EEG burst (see text). 
 
HRFs start after the onset of the electrical burst (t=0), peaks between 2-4 s, and 
slowly return to baseline. The latency of the CMRO2 response function is not 
significantly different from those of the HbT and CBF responses (Table 2-3). The 
CMRO2 response returns to baseline more rapidly than the hemodynamic responses 
(Figure 2-5). 
Table 2-3. Amplitudes and latencies of hemodynamic and metabolic impulse responses. 
 
HRF Peak amplitude (%) Time to peak (s) 
HbO 3.0 ± 0.2 2.6 ± 0.2 
HbR -1.8 ± 0.2 4.1 ± 0.2 
HbT 1.5 ± 0.1 2.2 ± 0.1 
CBF 5.7 ± 0.8 2.5 ± 0.1 
CMRO2 2.6 ± 0.5 2.1 ± 0.2  *Data represents average over 8 animals and standard errors 
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Confidence bounds on the estimation of CMRO2 from assumption of baseline HbT 
concentration 
Since we assumed baseline hemoglobin concentration and oxygenation to 
calculate CMRO2, we evaluated CMRO2 results for different baseline conditions. 
Changes in SO2 between 50% and 80% did not change CMRO2 as much as changes in 
hemoglobin concentration. Figure 2-6 shows the confidence bounds when the baseline 
HbT varied from 80 to 160 μM. 
 
Figure 2-6. Confidence bounds on the estimation of CMRO2 from assumption of baseline HbT concentration. 
Varying the assumption of baseline HbT concentration across the physiological extremes of 80 to 160 μM changes the 
magnitude of the CMRO2 response but does not change its profile significantly. Within this assumption range, 
metabolic responses do not occur before the onset of the burst. Peak metabolic rates also occur at the beginning of the 
burst and rapidly returns to baseline. 
 
Hemodynamic indices during burst suppression 
From the grand averages we can estimate the flow-metabolism coupling ratio, n, 
defined as the ratio of the fractional change in CBF to the fractional change in CMRO2 
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(Davis et al. 1998; Hoge et al. 1999; Blockley et al. 2013). The obtained value of n is 2.5 
± 0.3.  
Similarly, from the grand averages of the CMRO2 HRFs and the EEG burst 
lengths, we estimate by linear superposition that CMRO2 during a burst increases on 
average by 18 ± 4 percent relative to the basal metabolic rate during suppression. 
We also calculated the flow/volume coefficient, Φ = log(rHbT)/log(rCBF), and 
tested whether the Grubb's law (Grubb et al., 1974), which assumes a constant 
relationship between CBF and CBV changes, holds during bursts. The flow/volume 
coefficient we obtained is Φ=0.30 ± 0.04, and the Grubb flow/volume relationship 
predicts rCBV from rCBF extremely well with a Pearson's correlation coefficient r = 
0.999 for the whole period of the HRF (-2 to 14 s). 
 
Figure 2-7. Grubb's relationship between cerebral blood flow and volume during the burst response. Changes in 
cerebral blood volume were measured by NIRS in terms of changes in total hemoglobin concentration (solid line). The 
corresponding changes in CBF measured by DCS were transformed by the Grubb relationship into an estimate of the 
changes in total hemoglobin concentration (dotted line). The flow/volume coefficient in the relationship was 
determined by fitting the Grubb-estimated HbT response from DCS to the response measured by NIRS. The responses 
well agree and the recovered coefficient value of 0.30 ± 0.04 lies within the range reported as normal. 
  
55 
Cerebrovascular reactivity towards CO2 during burst suppression 
We further investigated the state of cerebral vessel tone during burst suppression 
by evaluating the cerebrovascular reactivity towards CO2 (CCO2R) during conditions of 
1% isoflurane, burst, and suppression in two animals with an explicit inspired CO2 
challenge (Figure 2-8). For a constant level of etCO2, absolute values of CBFi were 
greatest during 1% isoflurane and lowest during suppression. The variation in CBFi 
values was much greater for the burst periods than for the cases of 1% isoflurane and 
suppression. However, peak CBFi values during bursts did not exceed CBFi levels during 
1% isoflurane. The CCO2R was determined from the slope of best fit lines to be 3.1, 3.5, 
and 3.5 % CBFi/mmHg etCO2 (with r2 of 0.85, 0.65, 0.90) during 1% isoflurane, burst, 
and suppression, respectively. Similar behavior was observed in other animals, during 
periods of transitions between anesthetic levels when etCO2 levels often spontaneously 
change. For the 1% isoflurane case in one animal, CMRO2 was also determined as a 
function of etCO2 (Figure 2-9).   
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Figure 2-8. The cerebrovascular reactivity towards CO2 during conditions of 1% isoflurane, bursts, and 
suppression. Cerebrovascular reactivity measures the capacity of cerebral vessels to dilate. Average values of CBFi 
were calculated for 10 second intervals and plotted against the average level of etCO2 during the same period. For the 
burst periods, the peak value of CBFi during the burst is plotted instead of an average value. Cerebral blood flow was 
greatest under 1% isoflurane and lowest during suppression, which indicates mean flow-metabolism coupling remains 
intact. Variations in burst length and overlap cause cerebral blood flow to vary more in the burst group than in the other 
groups. Despite this large variation, peak cerebral blood flow during bursts does not exceed the amount of cerebral 
blood flow during 1% isoflurane. CCO2R remained normal under all conditions, demonstrating vessel tone was far 
from fully relaxed and the CBF response to bursts was not saturated. Results are shown for a single animal, but were 
repeated in a second animal.  
 
Figure 2-9.  Cerebral metabolism remains unchanged during hypercapnic challenge under 1% isoflurane in one 
animal. 
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Burst length dependent hemodynamic response functions 
On the eight animals with identical probe arrangements, we divided burst into two 
groups depending on their duration, i.e. bursts longer and shorter than 1 s, and determined 
the HRFs for these two groups. On average, 50±20 burst per animal had duration >1s and 
30±12 burst per animal had duration <1s. Average duration of longer bursts was 
1.82±0.06 s, and average duration of shorter bursts was 0.68±0.04 s. We found 
significantly larger HRF in hemoglobin concentration and blood flow for long bursts than 
short bursts (p <0.02 for hemoglobin concentrations; p <0.05 for CBF). Instead we did 
not see differences in CMRO2 response functions between long and short bursts. The 
total metabolism for short and long bursts are different, since the total response is 
calculated by convolved the HRFs with the different burst lengths. Figure 2-10 shows the 
averaged HRFs for >1s (thick lines) and <1s (thin lines) duration bursts.  
 
Figure 2-10. Burst length dependent hemodynamic response functions. Responses were determined by 
deconvolution fits of bursts with duration greater than 1 s (solid lines) and less than 1 s (dashed lines). Long duration 
bursts resulted in larger changes in hemoglobin concentration and blood flow, but not CMRO2. 
  
58 
Hemodynamic responses during anesthetic transitions 
Finally, we examined periods of transition from low-to-high and high-to-low 
isoflurane concentrations. During these anesthetic transitions, the EEG recordings 
progressed from continuous activity to sparse bursts, and the hemodynamic responses 
showed a dependence on the frequency of the bursts, with larger responses for lower 
burst repetition frequencies. Figure 2-11 shows two examples in two animals during 
transitions to and from 2% isoflurane. 
 
Figure 2-11. Fit using the burst HRF to hemodynamic activity during transitions between minimally active and 
burst suppressed EEG states. 
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Discussion 
Using a novel multimodal approach, we are able to measure dynamic changes in 
cerebral blood flow, oxygenation, and metabolism synchronously with electrocortical 
activity during burst suppression. We characterized the burst suppression hemodynamic 
response function for comparison with normal function activation, other pathological 
brain states, and predictions from theory. Specifically, we measured the magnitude and 
duration of SO2/OEF, CBV, CBF and CMRO2 before, during, and after electrical bursts. 
From these values, we also determined the flow-metabolism ratio, the value of the 
exponent in Grubb’s flow-volume relationship and the cerebrovascular reactivity towards 
CO2 to assess the effect of metabolic demand from burst activity on cerebral vascular 
function. 
We find EEG bursts occur across the cortex with highly synchronized and 
uniform hemodynamic responses. Our observation of global bursts agrees with prior 
characterizations of the spatial extent of electrical activity (Schwartz et al. 1989; Lewis et 
al. 2012) and time-average BOLD responses (Vincent et al. 2007; Liu et al. 2011). We 
extend previous works by measuring the dynamic coupling between electrical, 
hemodynamic, and metabolic activities. We find each electrical burst causes a 
corresponding hemodynamic response. However, while electrical bursts occur rapidly 
with sharp transitions to and from suppression, hemodynamic responses are slower and 
continue to evolve after the initiating electrical burst terminates. Hyperemic responses 
last longer than electrical bursts because vascular processes are slower than 
electrophysiological ones. Because of this physiological difference, electrical bursts 
  
60 
frequently occur while hemodynamic responses to previous bursts are still unfolding. 
Since bursts arise sporadically, the resulting hemodynamic profile is highly convolved, 
even as the bursts driving the response remain distinct electrically. We developed a 
deconvolution model to account for this overlap and predict the hemodynamic response 
to a series of EEG bursts. With the EEG data as an input, we regressed the model to the 
NIRS and DCS data to recover the impulse response function to a burst for hemoglobin, 
cerebral blood flow, and oxygen metabolism. 
We find the burst suppression hemodynamic response function is similar in all 
regards to the stereotypical functional hyperemia evoked by normal brain activation. A 
hemodynamic response promptly follows the initiation of the electrical burst with no 
hemodynamic activity occurring in the suppressed period immediately before the onset of 
a burst. The rate of oxygen metabolism rises rapidly at the beginning of the burst and 
then falls quickly back to baseline as the burst proceeds, with kinetics similar to 
functional activation. Hemoglobin concentrations return to baseline more slowly than 
does the rate of metabolism as the vascular response completes. Termination of the 
electrical burst elicits no further hemodynamic activity. 
Cortical oxygen supply and demand during bursts are also quantitatively similar 
to that of functional brain activation. The 18 percent increase in relative metabolism 
which we estimated occurs during a burst is comparable to the size of functional 
activation (Buxton 2010). We found the flow response is also well regulated with flow 
delivered in a two and half fold excess relative to metabolism. This ratio is similar to the 
values reported for normal flow metabolism coupling during functional hyperemia 
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(Buxton 2010). Furthermore, when the effect of CO2 on cerebral blood flow is taken into 
account, the absolute values of CBFi were greater during the minimally active EEG states 
of light anesthesia than during suppression. Flow-metabolism coupling therefore 
dominates over the direct vasodilatory actions of isoflurane for the dosages used in this 
study. The net effect of 2% isoflurane was a constriction of cerebral blood vessel in 
response to the anesthesia-induced reduction in cerebral metabolism. The values of peak 
blood flow during bursts were bounded on the low side by the levels of blood flow during 
suppression and on the high side by the levels during minimally active EEG. The great 
variation in burst blood flow between these bounds reflects the variable length and 
overlap of the bursts themselves. Since peak blood flow levels during bursts do not 
exceed the levels of the minimally active EEG state, the cumulative effects of bursts and 
the direct vasodilator actions of isoflurane do not cause vessels to dilate maximally. Thus, 
the observed burst flow-metabolism ratio has not been compromised by saturation of the 
flow responses. Metabolism during bursts therefore is less than during minimally active 
EEG. We conclude flow remains coupled to metabolism in the burst suppressed state.  
Vascular reactivity, elasticity, and blood volume remain normal during burst 
suppression. The exponent of the Grubb relationship was determined to be 0.30 during 
bursts, indicating blood flow and volume remain matched throughout the entirety of a 
burst (Jones et al. 2001). Vascular reactivity to CO2 ranged within normal from between 
3.1 to 3.5 percent CBFi/mmHg etCO2. Reactivity to CO2 had previously been reported to 
be normal for average blood flow during propofol-induced burst suppression according to 
transcranial Doppler measurements of MCA blood velocity (Matta et al. 1995). We now 
  
62 
show vascular reactivity to CO2 is normal in the cortical microvasculature and, by 
segmenting the response according to EEG activity, demonstrate reactivity remains 
normal during periods of both burst and suppression. Reactivity curves of cerebral blood 
flow versus etCO2 remain linear throughout their entire range without any signs of 
saturation, indicating basal vessel tone remains far from maximal dilation. 
Correspondently, blood volumes are not excessive. 
Despite the global extent of burst activity, we find the large simultaneous increase 
in aggregate demand during a burst does not exceed the capacity of the vasculature to 
supply oxygenated blood normally.  
The normal metabolism and hemodynamics during burst suppression is in stark 
contrast with other common electrophysiological pathologies. For example, both seizures 
and cortical spreading depression are associated with large cerebral metabolic and 
hemodynamic dysfunctions which lead to further secondary injuries. Activity during 
seizure are responsible for some of the highest rates of cerebral metabolism known 
(Brady et al. 2005). The resulting excessive cerebral blood flow can outstrip demand and 
become uncoupled from metabolism (Brady et al. 2005). Conversely, the hypermetabolic 
periods during seizures are often preceded by bouts of hypometabolism. Cortical 
spreading depression similarly causes excessive metabolism which often leads to oxygen 
supply-demand mismatch and risk of ischemic injury (Ingram et al. 2014; Wei et al. 
2014; Bornstädt et al. 2015). We find these complications are completely lacking in burst 
suppression, suggesting the risk of secondary metabolic or ischemic injury is minimal. 
This is consistent with previously reported reductions in mean cerebral metabolism 
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during burst suppression. We now show spontaneous burst activity itself is not 
metabolically or hemodynamically dysfunctional in the cortex, with the caveat that we 
did not investigate evoked bursts which may produce larger responses. Without 
addressing the potential impact of direct neuronal activity during burst suppression may 
have on brain health, we conclude cortical metabolic and hemodynamic behavior of burst 
suppression is an epiphenomenon. 
Mechanistically, we find a rise in cortical oxygen metabolism is not necessary to 
initiate or terminate a burst. The duration of a burst is not limited by deficits in cortical 
oxygen metabolism or blood supply. Furthermore, the magnitude of the metabolism and 
associated hemodynamic response depended on the duration of the burst, suggesting 
normal coupling with electrical activity remains intact. Our results do not address the 
impact changes in basal cortical metabolic rate may have on burst suppression. We also 
did not investigate the metabolic activities of deep brain structures. In particular, strong, 
synchronized thalamic discharges have been implicated in burst suppression (Steriade et 
al. 1994) and local metabolism in these regions may yet be found to have a role in their 
origin. 
Finally, our deconvolution model continues to predict hemodynamic activity 
accurately throughout transitions between minimally active EEG and burst suppression. 
We see a continuous transition from one to another without an abrupt change in brain 
state. We note that under our conditions the peak CBF of individual bursts never 
exceeded the level of CBF in the minimally active state, but did approach it as bursts 
overlapped. Furthermore, the variance of hemodynamic signals is also greater during 
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minimally active EEG than during suppression. This supports the hypothesis that 
hemodynamic activities under the minimally active state follow from electrical ones in a 
superposition of burst-like responses. Thus, resting-state hemodynamic signals still 
reflect neuronal activity even in the absence of an evoked response. Electrical activity 
during bursts is already known to be identical to the activity during minimally active 
EEG. Our results show the same for hemodynamic activities and support the idea that 
abnormal periods during burst suppression are the suppressed periods, not the bursts. 
Conclusion 
Cortical oxygen metabolism of bursts is similar to that of functional activation 
and evokes the regular machinery of neurovascular coupling to produce a conventional 
blood flow response. Combined DCS and NIRS measurements is a new approach which 
uniquely provides continuous, real-time assessment of regional cortical blood flow, 
oxygenation and metabolism in the lab and at the patient’s bedside. We demonstrate this 
method can detect anesthesia-induced changes in cerebral metabolism with sufficient 
temporal resolution to measure the rapid changes associated with neuronal activity such 
as bursts. The non-invasive nature of this technology makes it useful for clinical 
applications and investigations of changes in cerebral metabolism with anesthetic state 
and pathological condition. Monitoring the hemodynamic response to burst suppression 
under pathological conditions may have potential as indicator of supply-side problems of 
cerebral perfusion and oxygenation. In anesthesia, especially if coupled with the new 
methods of burst suppression targeted dosing, these spontaneous signals may provide the 
opportunity for automatic neuromonitoring to replace the evoked procedures used now. 
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CHAPTER THREE: TIME-DOMAIN DIFFUSE CORRELATION 
SPECTROSCOPY 
Introduction 
While the advantages of DCS make it nearly ideal for performing non-invasive, 
transcranial measurements of cerebral blood flow, quantification of the cerebral blood 
flow index (CBFi) is limited by low cerebral sensitivity and susceptible to inter- and 
intra- subject variability from differences in the optical properties of tissue. While DCS 
inherently has greater sensitivity to brain than NIRS by virtue of the greater weight given 
to higher blood flow and the preferential weight given to longer path-length photons 
(Selb et al. 2014), the confounding contribution of extra-cranial scalp and skull layers 
cannot be neglected. For example, different pressure applied to the probe on the scalp can 
alter superficial blood flow and contaminate CBFi estimates (Mesquita et al. 2013). 
Furthermore, the tissue reduced scattering coefficient (µs') is an important parameter for 
the quantification of CBFi, but is not constant across individuals or even anatomical 
location. A 20% error in the scattering coefficient leads to a 20% error in measured CBFi 
estimates (Irwin et al. 2011), as predicted theoretically (Boas and Yodh 1997). Variations 
from extracranial sources or optical tissue properties reduce the statistical power of DCS 
measurements and hamper the ability to develop clinical thresholds for abnormal CBFi. 
We have developed a novel method, time-domain diffuse correlation spectroscopy 
(TD-DCS), to address both of these limitations directly (Figure 3-1). By employing a 
novel long coherence pulsed laser, we measure photon time-of-flight (TOF) through the 
tissue and DCS fluctuation dynamics simultaneously. By moving DCS operation from 
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continuous wave (CW) to the time-domain, we exploit the many advantages of time-
resolved reflectance spectroscopy (TRS) where a train of ultra-fast laser pulses is used to 
measure the TOF through the tissue and their distribution, the so called temporal point 
spread function (TPSF) (Ijichi et al. 2005). This enables us, for the first time, to employ 
time-gating strategies (Selb et al. 2005; 2006) used in TRS for DCS blood flow 
measurements, and to realize improvements which are not possible when the two 
techniques are performed independently (Weigel et al. 2016).  
 
 
Figure 3-1. TD-DCS uses trains of long-coherence length laser pulses to measure both times-of-flight and path-
length dependent autocorrelation functions at the detector for improved determination of blood flow. The figure 
illustrates two different photon paths (purple and green) in highly scattering media for the light pulse at time t (dashed 
line) and at time t+τ (solid line). On average, light travelling in more superficial layers (purple paths) has a shorter 
time-of-flight (TOF) than light traversing deeper (green paths) into the tissue (time differences in the 10-100ps time 
scale). The difference in the paths at t and t+τ is due to the motion of the red blood cells, which causes flow-dependent 
fluctuations in the detected intensity on the 10-1000 nanosecond timescale. Time-tagging photons TOF (ps) and 
absolute arrival (ns) allows multiple analyses to be performed from the same data stream. In particular, photons can be 
separated by TOF into those travelling shorter (purple) or longer (green) paths through the tissue enabling calculation 
of the DCS correlation function from photons traveling to different depths in the tissue. 
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In our approach, time-correlated single photon counting (TCSPC) is used to time-
tag each detected photon with two values, the time-of-flight from source to detector to 
obtain the TPSF, and the absolute arrival time to calculate the temporal autocorrelation 
function for DCS. By evaluating correlation functions over different time gates of the 
TPSF, TD-DCS is able to differentiate between early and late arriving photons and 
evaluate BFi at different depths within the tissue. Since the time-gates are calculated from 
the TOF tag on every detected photon, multiple time gates are applied in parallel which 
maximizes the utilization of the detected photons. Monte Carlo simulations of time-gated 
intensity autocorrelation functions under realistic conditions demonstrate an 80% 
improvement in cerebral sensitivity. Furthermore, the actual tissue optical scattering and 
absorption coefficients are also determined from the TPSF, improving the reliability of 
absolute CBFi comparisons within and between subjects.  
We have constructed a TD-DCS prototype and performed measurements on liquid 
phantoms which mimic human optical properties and on small animals, demonstrating 
that our approach has the potential to be rapidly translated to humans and into a clinically 
viable, non-invasive, comprehensive cerebral hemodynamic monitoring method with 
significant advantages over existing methods. 
Methods 
Monte Carlo simulations 
Transcranial optical methods must balance the sensitivity of the measurement to 
the brain with the magnitude of the detected signal. Using larger distances between 
sources and detectors increases the proportion of signal arising from the brain but 
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exponentially reduces signal strength. Similarly, applying a late time-gate increases brain 
sensitivity but reduces signal levels as photons outside the gate are rejected. Monte Carlo 
simulations demonstrate that the loss in signal strength from a time-gated diffuse 
correlation spectroscopy (DCS) measurement can be compensated by reducing the source 
detector separation, yielding a net improvement in sensitivity to the brain with respect to 
existing techniques while retaining comparable signal strength (Figure 3-2).  
A two-layer slab model was simulated to describe the behavior of a transcranial 
measurement of an adult brain through a realistic layer of scalp and skull. In addition to 
the usual effects of optical absorption and steady-state scattering, momentum transfer 
from dynamic scattering simulated the effect of blood flow (BF) on the DCS signal (Selb 
et al. 2014). The geometrical, optical and flow properties of the layers are representative 
of a single upper extracerebral layer representing scalp and skull and a lower layer 
representing brain. In particular the thickness of the first layer was set to 10 mm, the 
optical properties (reduced scattering (μs') and absorption (μa) coefficients) in the two 
layers were set to μs'=12 cm-1, μa=0.10 cm-1, and the Brownian Diffusion coefficient (𝑂𝑂𝑟𝑟) was set to 𝑂𝑂𝑟𝑟=1Ee-6 mm2/s in the top layer and 𝑂𝑂𝑟𝑟=6e-6 mm2/s in the bottom layer, 
as in (Selb et al, 2005). Sensitivity to the brain was determined by the fraction of the total 
signal attributable to the bottom layer. In particular, for TD-NIRS, we simulated the 
detected intensities for the baseline condition, a 20% increase in μa in the bottom layer, 
and a 20% increase in μa in both layers. For TD-DCS, we simulated the detected 
autocorrelation functions for the baseline condition, a 20% increase in 𝑂𝑂𝑟𝑟 in the bottom 
layer, and a 20% increase in 𝑂𝑂𝑟𝑟 in both layers. Next we computed the retrieved 
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absorption and 𝑂𝑂𝑟𝑟 by for each case assuming a semi-infinite homogeneous medium. 
Finally, the relative sensitivity to the bottom layer was computed as the ratio of the 
retrieved relative change in μa or 𝑂𝑂𝑟𝑟 for a bottom layer only change, over the retrieved 
relative change in μa or 𝑂𝑂𝑟𝑟 for a change in both layers. Note that for NIRS, the relative 
brain sensitivity is simply the ratio of the bottom-layer partial path length over the total 
path length, as we detail further in (Selb et al. 2014).   
For continuous wave (CW) NIRS measurement of cerebral hemoglobin 
concentration, source-detector separations are typically 3 cm in adults. Hence we take the 
detected flux at this distance as a benchmark to which all other fluxes are compared. At 
this separation, only 23% of the CW-NIRS signal and 38% of the CW-DCS signal arise 
from the bottom layer. Due to the small aperture detection requirements for DCS, DCS 
measurements are often made at a shorter separation of 2 cm to increase the detected 
signal levels. At this shorter separation, the flux increases by a factor of 16, but the CW-
DCS sensitivity to the bottom layer drops to 17%. At a 1 cm separation, though the flux 
increases 500-fold, both CW-NIRS and CW-DCS modalities are essentially insensitive to 
the bottom layer. Thus, although CW-DCS does have greater sensitivity to the brain than 
CW-NIRS, in all practical cases a majority of the signal in CW methods still arise from 
the scalp, not from the brain.  
In contrast, time-gating the signals such that only late arriving photons are 
considered, greatly increases the fraction of the signal arising from the brain. The 
simulation shows that when the separation is reduced to 1 cm, a time gate starting at 1.5 
ns maintains the same flux through the gate as the CW flux with a 3 cm separation. Under 
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these conditions, the TD-NIRS signal from the bottom layer increases to 37% and the 
TD-DCS signal from the bottom layer increases to 68% with respect to 23% and 38% 
respectively for the 3 cm CW case. 
 
 
Figure 3-2. Results of the TD-DCS Monte Carlo simulations. Panel (d) Slab geometry and optical properties of the 
two layers. Panel (a) reports the cumulative photon counts arriving after the specific delay time vs. the gate start time. 
Note that the gate start time indicates the time after which the arriving photon counts are integrated. Photon counts are 
normalized with respect to the photon counts detected at a 3 cm separation with zero gate start time (i.e. CW). While 
fewer photons in the TPSF have long times-of-flight, the total number of detected photons increases exponentially with 
shorter source-detector separations. Panels (b) and (c) report the sensitivity to the bottom layer (brain) as a function of 
gate start times for NIRS, and DCS, respectively. By using late time-gates, brain sensitivity increases. As the lines 
across the figures show, by using shorter source-detector separations, we can maintain the same number of photons as 
CW at 3 cm but gain in brain sensitivity by using late time-gates.   
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Theoretical considerations 
Boas et al. (Boas et al. 1995) showed that the decay of the intensity 
autocorrelation function could be described by a correlation diffuse equation that is 
similar to the regular photon diffusion equation but replacing the traditional absorption 
coefficient (𝜇𝜇𝑎𝑎) with a dynamic absorption coefficient. That is, in the traditional photon 
diffusion equation, 𝜇𝜇𝑎𝑎 is replaced with the dynamic absorption term 𝜇𝜇𝑎𝑎 + 2𝜇𝜇𝑜𝑜′𝑂𝑂𝑟𝑟𝑘𝑘𝑜𝑜2𝜏𝜏 to 
obtain the correlation diffusion equation, where 𝜇𝜇𝑜𝑜′  is the reduced scattering coefficient, 
𝑂𝑂𝑟𝑟 is the Brownian diffusion coefficient acting as an index of blood flow, 𝑘𝑘𝑜𝑜 = 2𝜋𝜋𝑛𝑛 𝜆𝜆⁄  is 
the wavenumber of light, and 𝜏𝜏 is the correlation time.  Thus, the solution of the time 
domain-correlation diffusion equation can be obtained from the traditional TD-NIRS 
solution by making this replacement. For a semi-infinite medium, the TD-DCS solution 
for the field temporal autocorrelation function, 𝐺𝐺1, is thus 
𝐺𝐺1(𝜌𝜌, 𝑧𝑧 = 0, 𝑠𝑠) =   𝑐𝑐 � 3𝜇𝜇𝑠𝑠′4𝜋𝜋𝑡𝑡𝑎𝑎�3 2� 𝑠𝑠𝑥𝑥𝑒𝑒[−(𝜇𝜇𝑎𝑎 + 2𝜇𝜇𝑜𝑜′𝑂𝑂𝑟𝑟𝑘𝑘𝑜𝑜2𝜏𝜏 )𝑐𝑐𝑠𝑠] 𝑠𝑠𝑥𝑥𝑒𝑒 �− 3𝜇𝜇𝑠𝑠′𝜌𝜌24𝑡𝑡𝑎𝑎 � �𝑠𝑠𝑥𝑥𝑒𝑒 �− 3𝜇𝜇𝑠𝑠′𝑧𝑧024𝑡𝑡𝑎𝑎 � −
𝑠𝑠𝑥𝑥𝑒𝑒 �−
3𝜇𝜇𝑠𝑠
′(𝑧𝑧0+2𝑧𝑧𝑏𝑏)2
4𝑡𝑡𝑎𝑎
��        (Equation 3-1) 
where t is the arrival time of the photons with respect to the laser pulse at t=0, and ρ is the 
source-detector separation.  
The normalized field temporal autocorrelation function is obtained by dividing 
𝐺𝐺1(𝜏𝜏) by 𝐺𝐺1(𝜏𝜏 = 0). Doing so, we obtain the path-length dependent normalized field 
temporal autocorrelation function 
𝑔𝑔1𝑜𝑜(𝜏𝜏, 𝑠𝑠) = exp (−2𝜇𝜇𝑜𝑜′𝑂𝑂𝑟𝑟𝑘𝑘𝑜𝑜2𝑠𝑠𝜏𝜏),      (Equation 3-2) 
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where we have replaced the transit time of light through the tissue, t, with the path-length 
of light through the tissue, s. This is an important equation as it indicates that the decay 
rate of the field temporal auto-correlation function increases linearly with the photon 
path-length. This makes sense as the decay rate increases with the number of dynamic 
scattering events and the number of dynamic scattering events increases linearly with the 
photon path-length, as has been detailed extensively in the past (Maret et al. 1987; Pine et 
al. 1988; Yodh et al.1990). Another important result of this equation is that the path-
length dependent decay of 𝑔𝑔1𝑜𝑜(𝜏𝜏, 𝑠𝑠) is independent of the absorption coefficient of the 
medium.  
For historical completeness, we note that 𝑔𝑔1𝑜𝑜(𝜏𝜏, 𝑠𝑠) was originally derived by first 
principles (Maret et al. 1987) and extended to CW-DCS by integrating over the 
distribution of detected photon path-lengths, i.e. 
𝑔𝑔1(𝜏𝜏) = ∫𝐵𝐵𝑠𝑠 𝑃𝑃(𝑠𝑠)𝑔𝑔1𝑜𝑜(𝜏𝜏, 𝑠𝑠).       (Equation 3-3) 
For light diffusion through a highly scattering medium, 𝑃𝑃(𝑠𝑠) is given by the solution of 
the time-domain photon diffusion equation. For a semi-infinite medium, the solution of 
Equation 3-3 would be equal to the solution of the correlation diffusion equation for CW-
DCS given by Equation 3-1.  
Experimentally, with TD-DCS we measure the path-length dependent normalized 
intensity auto-correlation function (g2s), which is related to 𝑔𝑔1𝑜𝑜 by 
𝑔𝑔2𝑜𝑜(𝜏𝜏, 𝑠𝑠) = 1 + 𝛽𝛽𝑔𝑔1𝑜𝑜2 (𝜏𝜏, 𝑠𝑠),       (Equation 3-4) 
where 𝛽𝛽 accounts for loss of coherence due to the spatial and temporal coherence of the 
detected light.  
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In CW-DCS the temporal coherence is maximized by choosing lasers with a 
coherence length longer than the distribution of photon path-lengths through the 
scattering medium. We maximize the spatial coherence by using a single mode fiber for 
detection, but as we generally do not use a polarizer, the best value of 𝛽𝛽 we can achieve 
in conventional CW-DCS is 0.5. For TD-DCS, the short coherence length of the pulse of 
light reduces the temporal coherence. Following the formalism of (Bellini et al. 1991), we 
calculated 𝛽𝛽 for different coherence lengths, different time gate widths and different start 
times for the time gate along the TPSF to estimate the influence of different pulse 
parameters on the TD-DCS SNR. For a source-detector separation of 1 cm, index of 
refraction n=1.34, 𝜇𝜇𝑎𝑎=0.10 cm-1 and 𝜇𝜇𝑜𝑜′=10 cm-1, as we used for the Monte Carlo 
simulations above, and measuring all photons, we find that 𝛽𝛽 is reduced to 0.15 when 
using a 100 ps pulse of light. Longer laser pulses have longer coherence lengths, larger 𝛽𝛽, 
and more photons, but reduce the accuracy with which we can path-length resolve the 
detected light and estimate the scattering coefficient from the TPSF measurements.  
Photon budget / SNR considerations 
The competing operational requirements of TRS and DCS are a challenge for 
sustaining a suitable detected photon flux for an acceptable signal-to-noise ratio (SNR). 
TRS requires short-pulsed illumination with maximum repetition rates limited by the 
duration of the TPSF to frequencies of up to 100-200 MHz, which decreases the 
measurement duty cycle by a factor of 50 with respect to CW-DCS operation. DCS 
requires small detection apertures similar in size to a single laser speckle, a requirement 
typically enforced by detection through single-mode fibers. The 5 μm mode field 
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diameters of the single mode DCS detector fibers are an order of magnitude smaller than 
the 50 μm core diameters of the graded-index multimode fibers typically used for TRS 
detection and have a corresponding smaller photon detection efficiency. In our approach, 
these factors are compensated by employing a pulsed light source with an average power 
two orders of magnitude greater than the pulsed laser diodes typically employed for TRS 
(Contini et al. 2006; Torricelli et al. 2014) and single photon counting detectors highly 
sensitive to the near infrared.  
The effective detected photon flux is further reduced as a consequence of the 
time-gating scheme which increases the sensitivity of the measurement to the deeper 
layers of the tissue. The increase in sensitivity is achieved by considering only the 
fraction of detected photons that have travelled the longest distances through the tissue. 
This is performed by time-gating the signals such that only late arriving photons in the 
TPSF are included in the calculation of the DCS correlation function. Since the unwanted 
photons outside of the gate are excluded, the flux contributing to the blood flow signal is 
reduced. In principle, the reduction in SNR from the reduced flux through a late gate can 
be overcome by decreasing the source-detector separation until the flux through the gate 
matches the level of the CW signal obtained at the original separation distance. The 
increase in sensitivity from the delayed time-gate should be greater than the loss incurred 
from the shorter separation, yielding a net improvement in sensitivity with no loss in 
SNR. This strategy has been successfully employed for the null separation method in 
time domain near infrared spectroscopy (TD-NIRS) (Pifferi et al 2008; Tosi et al. 2011). 
We have extended this concept to TD-DCS and demonstrated, with Monte Carlo 
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simulations that when the source-detector separation is reduced to 1 cm, a time gate 
starting at 1.5 ns maintains the same flux through the gate as the CW flux with a 3 cm 
separation. Under these conditions, not only do we maintain the same flux but we almost 
double the TD-NIRS and TD-DCS sensitivity to the brain compared to CW. The Monte 
Carlo simulations suggest gated TD-DCS is feasible from the photon budget viewpoint, 
and, show, for the first time, that we can achieve greater sensitivity to the brain than to 
the scalp in human adults using DCS. 
The signal-to-noise ratio for a DCS measurement is not only determined by the 
detected photon flux but also depends on the amplitude of the correlation curve at zero 
correlation time τ=0. The amplitude is determined by the value of the coherence factor, β 
(Equation 3-4). Any reduction of β, results in a corresponding reduction in SNR in the 
determination of the decay rate of the correlation function. β is largely determined by the 
maximum coherence of the light arriving at the detectors. The short illumination pulse 
required for TD-DCS reduces the coherence length of the source compared to the CW 
case. For a pulsed source, the greatest coherence length for a given pulse duration occurs 
when the optical pulse is transform-limited. Transform-limited pulses represent the upper 
bound for the coherence length, given in this case by the product of the pulse temporal 
width and the speed of light. In practice, chirping and other phase artifacts in the pulse 
can reduce the coherence length below this limit. When the coherence length of DCS 
illumination is less than the difference between the longest and shortest photon path-
lengths through the tissue, β is reduced as interference is diminished between photons 
with path-length differences greater than the coherence length. The dependency of β on 
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coherence for short-coherence CW illumination has been derived by Bellini (Bellini et al. 
1991) with a theory that we apply to short laser pulses and time-gates. Bellini predicts 
that the contributions of photons to the correlation function are modulated by a Gaussian 
envelope with a width set by the coherence length. Photons with times-of-flight outside 
this envelope diminish the amplitude of the correlation function and should not be 
included in the gate. Furthermore, as predicted by Bellini, β depends on the distribution 
of path-lengths within the gate, and further decreasing the gate width below the 
coherence length further decreases the path-lengths distribution and increases β. Hence, 
to maximize β, the gate duration should be smaller than the coherence length, and 
multiple time gates of shorter duration are preferred for TD-DCS rather than a single 
large monolithic time-gate. Although each individual narrow gate has a lower β and 
photon flux than in the CW regime, fitting many gates simultaneously improves the SNR 
in the estimate of the blood flow index since the photons in all gates are used in the 
estimation. Based on these considerations, we find that utilizing narrow time gates allows 
us to optimize the analysis of TD-DCS measurements. 
Prototype TD-DCS device 
Since TRS and DCS are both photon-counting techniques with similar 
requirements for photon detection rates, a unified detection pathway common to both 
modalities is readily feasible. However, contradictory requirements for generating DCS 
correlation and TRS time-of-flight signals complicate efforts to combine the two 
techniques simultaneously. Typically, DCS is performed with a CW laser of coherence 
length longer than the difference between the longest and shortest paths through the 
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tissue to ensure photons interfere fully at the detector. TRS typically utilizes ultra-fast 
illumination pulses of durations as short as picoseconds to minimize convolution of the 
time-of-flights with the impulse response function of the device. However, the effective 
coherence length of these ultrafast pulses is too short for the photons to remain correlated 
at the detector. We demonstrate theoretically and experimentally that both conditions can 
be relaxed by using pulses of tens to hundreds of picoseconds in width, which are 
sufficiently short for TRS measurements while maintaining sufficient coherence length 
for DCS measurements. In particular, exploiting recent advances in laser sources, 
detectors, and electronics, we have found practical solutions which enabled us to build 
the first TD-DCS device (Figure 3-3) and, for the first time, to obtain the synergistic 
benefits achieved only when TRS and DCS modalities are performed simultaneously. 
  
 
Figure 3-3. Schematic diagram of the novel TD-DCS device. We modified an 852 nm DBR laser to provide 150 
picosecond pulses. We used an electrically pumped tapered diode amplifier to amplify the peak optical power of the 
laser while maintaining its coherence length. Amplification enables adequate detected photon flux through the tissue. 
New red-enhanced SPAD detectors are used to detect photons with high sensitivity and time resolution. Custom time-
to-digital converters (TDC) are used to determine the time-of-flight for the photons through the tissue. Finally, we built 
a custom FPGA board to collect the TOF tag from the TDC and merged it with the absolute arrival time used to 
calculate the correlation functions.   
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The key element of the new device is a picosecond pulsed laser source with high 
peak power. Such a laser is not readily available commercially but requires modifying 
commercial components. We developed a TD-DCS light source based on a two-stage 
laser master oscillator and amplifier (MOPA) configuration (Poelker 1995; Kangara et al. 
2014). As a seed laser for the amplifier, we used a monolithic distributed Bragg reflector 
(DBR) laser at 852 nm with CW coherence length of 10 m and 280 mW average optical 
power (PH852DBR280TS, Photodigm, Inc.). Optical pulses of durations of 65 - 185 ps 
are created by electrically gain-switching the seed laser using a picosecond pulsed laser 
driver (T165-9, Highland Technology, Inc.). We amplified the peak optical power to 2 
Watts via stimulated emission from an electrically pumped tapered diode amplifier (m2k-
TA-0850-3000-DHP, m2k-laser GmbH). The wave vectors of the seed laser photons are 
exactly cloned by stimulated emission, so the amplifier output preserves the coherence 
and pulse properties of the source. Low seed power is used to avoid mode-hopping or 
distortion of the pulse. To maximize the illumination duty-cycle, we used repetition rates 
of 150 MHz, a rate at which the 4-5 ns long TPSFs do not overlap. Using pulse durations 
of 150 ps, the average power is up to 50 mW, similar to those used in conventional DCS, 
and safe for human use when appropriately diffused over an area larger than 1 mm2, 
according to the ANSI standard.  
Other key features of this device include a new class of red-enhanced single 
photon avalanche diode (SPAD) detectors (Giudice et al. 2012; Gulinatti et al. 
2012)(PDM-R-FC, SPADlab, Politecnico di Milano and MPD Srl) which combine the 
high-temporal resolution (nominally 60 ps FWHM) needed for time gating with the high 
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photon detection probability in the near infrared necessary for penetrating centimeters of 
tissue. Each detector is paired with a time-to-digital converter (TDC) to measure the TOF 
by time-correlated single photon counting (TCSPC) using custom TDC-cards (Tamborini 
et al. 2014)(SPADlab, Politecnico di Milano) with 20 ps RMS precision and conversion 
rates in excess of 5 MHz. Finally, we have built a custom field-programmable gate array 
(FPGA) board to pair the TDC result with photon arrival times from a counter inside the 
FPGA locked to the laser clock. Each detected photon is time-tagged by two values, a 
fine resolution value for the time of flight from source to detector for the TPSF, and a 
coarse resolution value for the absolute arrival time to calculate the temporal correlation 
functions for DCS. We adopted the time-tagging strategy for DCS from fluctuation 
correlation spectroscopy which enables time-gated separation of a single photon stream 
by fluorescence lifetime into separate autocorrelation functions (Böhmer et al. 2002; 
Maret et al.1987). For maximum flexibility in the analysis, time-gating and 
autocorrelations are currently not implemented in the FPGA, but are instead performed in 
software after the photon events are transferred from the FPGA. 
Initial measurements were performed with a commercial time-correlated single 
photon counting module (SPC-600, Becker Hickl) prior to the adoption of our custom 
device. However, any commercial module capable of performing time-resolved 
fluorescence correlation spectroscopy should be compatible with TD-DCS. The 150 MHz 
laser clock was divided by eight to bring the TCSPC stop signal rate to within the range 
of the converter. The stop signal rate is a trade-off between minimizing the effects of 
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non-linearity of the converter and the length of the conversion dead-time, which sets the 
maximum conversion rate. 
Planar structure SPADs, such as those commercially available from MPD, have 
superior timing resolution, but their thin photon absorption region limits their sensitivity, 
especially in the near infrared. Reach-through structure SPADs, such as those 
commercially available from Excelitas, have greater sensitivity but reduced timing 
resolution. At 852 nm, the detection efficiency of traditional planar structure SPADs is 
only 10% while the reach-through structure SPADs can achieve 50%. We found the 30% 
efficiency (Gulinatti et al. 2012) of red enhanced planar structure SPADs was sufficient 
for TD-DCS measurements and allowed us to trade some photon sensitivity for better 
timing resolution. However, commercial reach-through structure SPADs suitable for 
time-resolved measurements should also be suitable for TD-DCS with the opposite 
tradeoff of worse timing resolution for better sensitivity. 
The coherence factor 𝛽𝛽 can be doubled by using a polarizer with the tradeoff of 
reducing the photon flux by more than half. The loss of flux may be compensated by 
increasing the illumination intensity if the measurement is TSPC converter limited.  
After-pulsing from the SPADs can limit the resolution of the measured correlation 
functions below correlation times of one microsecond. The effects of after-pulsing can be 
removed by beam-splitting a single mode detector fiber into two detectors and calculating 
their cross correlation function. 
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Homogeneous phantom experimental methods 
For the experiments presented in Figures 3-4, 3-5 and 3-7, we used whole milk 
diluted with water (ratio 1:4) to obtain a scattering coefficient of 𝜇𝜇𝑜𝑜′=6.2 cm-1 and an 
absorption coefficient 𝜇𝜇𝑎𝑎=0.04 cm-1 (water) at 852 nm, as measured by a combined 
Frequency-Domain NIRS and CW-DCS device (MetaOx, ISS, Inc.). While there is no 
actual flow in the liquid phantom, the Brownian motion of the scattering particles 
contributes to the Brownian diffusion coefficient 𝑂𝑂𝑟𝑟, and for the diluted milk at room 
temperature with CW-DCS we measured 𝑂𝑂𝑟𝑟=8.5e-9 cm2/s. For the experiment of Figure 
3-6, we used liquid silicone, which is more viscous than milk, to span a larger range of 
speeds, when stirring the phantom. The optical properties of the silicone were 𝜇𝜇𝑜𝑜′=3.5 cm-
1, 𝜇𝜇𝑎𝑎=0.04 cm-1 at 852nm and 𝑂𝑂𝑟𝑟=1.3e-9 cm2/s. All liquid phantoms were contained in a 
2000 ml glass beaker and maintained at the room temperature of 24 degrees Celsius. The 
source and detector fibers were immersed a few mm into the liquid and the source-
detector separation was set to 1 cm. Laser power at the distal end of the source fiber was 
6.5 mW, with a laser pulse width of 150 ps, and a repetition rate of 150 MHz. For the 
milk experiments we acquired 276 million photons in 2800 seconds. 
Small animal experimental methods 
Two female Sprague–Dawley rats were included in this study. Experiments and 
procedures were approved by the Massachusetts General Hospital Subcommittee on 
Research Animal Care. During all surgical procedures, the animals were anesthetized 
with isoflurane (2–2.5%) administered via a facemask in a gas mixture of 80% air and 
20% oxygen. After tracheotomy and cannulation of the femoral artery and vein, animals 
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were artificially ventilated and mounted on a stereotactic frame. Heating blankets 
maintained core temperature at 36.5–37.5 °C. An optical probe consisting of one source 
and two detector fibers was secured on the animal head. Isoflurane anesthesia of 1-1.2% 
was maintained for the rest of the experiment. Continuous monitoring of arterial blood 
pressure, pulse oximetry arterial oxygen saturation, heart rate with ECG, end-tidal CO2, 
and blood sample recording of arterial pH, PaO2, and PaCO2 at the beginning, middle and 
end of the experiment, assured maintenance of basic physiological parameters. TD-DCS 
data were acquired for a baseline normocapnic period of 10 min followed by a 10 min 
hypercapnic challenge and by a final 10 min normocapnic period. Inspired CO2 was 
increased during hypercapnia to 4% and PaCO2 nominally increased from 35 mmHg to 
45 mmHg. While in Figure 3-8 we report results on only one animal for brevity, results in 
the two animals were consistent. 
Results 
Measurements of β in homogeneous phantoms 
We experimentally show with measurements in a homogeneous turbid phantom 
the dependence of β on time gate width and demonstrate that β increases when 
decreasing the time gate width below the coherence length of the pulsed laser (Figure 3-
4). When the measured path-length dependent normalized intensity temporal 
autocorrelation function (g2s) (Equation 3-4) is calculated using every detected photon, 
regardless of the time-of-flight, the result is equivalent to a CW measurement with a low 
coherence source. However, as the width of the time gate is decreased, β increases as the 
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differences in path-lengths of the photons arriving through the gate decrease with respect 
to the coherence length and we obtain a path-length resolved estimate of BFi. 
Experimentally, in addition to showing the β dependence on the width of the gate 
used to calculate the correlation function (Figure 3-4), we also observed a dependence of 
β on the start time of the narrow gates along the TPSF. In particular, for early gates, 
before the TPSF peak, β is higher than for gates after the peak (Figure 3-5). We believe 
this behavior is due to the steepness of the TPSF effectively shortening the distribution of 
photon path-lengths through the gate. 
 
 
Figure 3-4. TD-DCS measurements of a diluted milk phantom demonstrate the β dependence on time gate 
width. a) TPSF with superimposed gates of different widths all starting right before the peak at t= 250 ps. The gate 
labeled CW is 3000 ps wide. b) Measured path-length dependent normalized intensity temporal autocorrelation 
functions for the corresponding gates. The numbers in the legend indicate the gate width. c) The correlation amplitude 
β as a function of gate width for the corresponding gates.  β increases with narrower time gates as predicted by Bellini 
(Bellini et al. 1991). 
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Figure 3-5. β as a function of time delay. Measured β for twelve 48 ps gates shown in Figure 3-4, during the same 
experiment. 
 
Simultaneous measurement of photon time-of-flight and temporal intensity 
autocorrelation function in a moving homogenous phantom 
To demonstrate the effect of motion on the autocorrelation function, we added 
motion to a liquid phantom using a magnetic stirrer and we incrementally increased the 
stirring rate. Figure 3-6 shows how the TPSF remains constant with increasing stirrer 
speed, since the TPSF depends only on scattering and absorption, while g2s, which in 
addition to scattering depends on motion, decays faster with increased stirrer speed.   
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Figure 3-6. TD-DCS signals change with scatterer speed. TPSF (panel a) and temporal intensity autocorrelation 
function (panel b) for a silicone liquid phantom at different stirrer settings. g2s is calculated over a 240 ps gate across 
the TPSF peak. By changing stirrer speed, the g2s decay rate increases, while the TPSF remains constant since only the 
speed of the scattering particles within the liquid phantom is changing. 
 
Measurement of Brownian motion from the path-length-dependent correlation function in 
a homogeneous phantom 
By using short duration time gates, the gated correlation curve is simply described 
by the path-length-dependent normalized field temporal autocorrelation function g1S 
without convolution over the path-length distribution needed in CW-DCS (Maret et al. 
1987; Pine et al. 1988; Yodh et al.1990) (see Equations 3-2 and 3-3). Diffusion theory 
predicts that the decay rate of g1S depends linearly on the path-length of the light with 
zero decay rate at zero path-length. We experimentally verified this in a homogeneous 
turbid phantom (Figure 3-7).  The x-intercept of the decay rate versus path-length 
corresponds to tO, the temporal offset of the laser pulses in the experiment, and the slope 
is proportional to the product of the reduced scattering coefficient (µs’) and the Brownian 
diffusion coefficient (𝑂𝑂𝑟𝑟). With TD-DCS, as the reduced scattering coefficient can be 
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estimated from the TPSF, 𝑂𝑂𝑟𝑟 can be obtained from the decay rate of individual path-
length dependent autocorrelation functions, or from the slope of the decay rate vs path-
length.  
 
Figure 3-7. Linear dependence of the decay rate of g1S on the light path length in a homogeneous turbid 
phantom. a) TPSF with superimposed twelve gates of fixed width (48 ps) starting at different time delays. b) Measured 
path-length dependent normalized field autocorrelation functions for the corresponding gates. c) Slope of the field 
autocorrelation functions at the 12 gates as a function of path-length (i.e. time delay · speed of light in water). The 
small gray symbols correspond to g1s slopes for overlapping gates 48 ps wide shifted 12 ps each. The linear fit is done 
considering all of the slopes, the intercept is to and the slope is proportional to DB·µs’. The resulting DB is 1.0e-6 
mm2/s, in close agreement with the DB measured using a CW-DCS system (0.85e-6 mm2/s). 
 
Measurements of Cerebral Blood Flow in Rats Under Hypercapnic Challenge 
Transcranial measurements were performed in vivo on two anesthetized rats under 
mechanical ventilation with a source to detector separation of 5 mm. These experiments 
provide the opportunity to measure blood flow in a layered tissue. Correlation curves 
were calculated for narrow width time gates around the peak of the TPSF (Figure 3-8a). 
In contrast to the homogeneous phantom, the decay rate of the path-length-dependent 
correlation functions in the rats showed two regimes (Figure 3-8b). The decay rate for 
early arriving photons versus path-length exhibits a slower slope than later arriving 
photons. Assuming the effective scattering coefficient remains constant over the two 
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regimes, the change in slope can be interpreted as different flows, with short path-length 
photons reporting slower flow from the scalp and long path-length photons reporting a 
faster flow from the brain. By analyzing the longer path-length photons, the sensitivity of 
the blood flow measurement to the brain is increased, this is not feasible with a CW-DCS 
measure.  
To investigate the sensitivity of the measurement to cerebral blood flow, we 
modulated cerebral blood flow with a hypercapnic challenge of inspired CO2. CO2 
differentially increases blood flow in the brain without increasing blood flow in the 
peripheral circulation (Lennox et al. 1932). Under the challenge, we verified that the 
slope of the path-length-dependent decay rate for short path-lengths did not change, while 
it increased for longer path-lengths. The measured 55% increase in CBFi is consistent 
with the expected increase due to this hypercapnic challenge. 
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Figure 3-8. TD-DCS measurements on a rat during two periods of normocapnia (blue and green lines) and 
hypercapnia (red line).  (a) TPSF measured at a source-detector separation of 5 mm. The TPSF during normocapnia 
and hypercapnia are overlapping, suggesting negligible changes in tissue scattering and absorption with hypercapnia. 
The shaded areas span the range of the 37 gates 48 ps wide shifted 12 ps each. The gray shaded area indicate the gate at 
the border between early (light blue) and late (pink) gates.  (b) Slope of the field autocorrelation functions for the 37 
gates as a function of path-length during normocapnia (blue and green symbols) and hypercapnia (red symbols). The 
open circles correspond to the 13 early gates, the closed circles correspond to the 24 late gates. The decay rate is much 
higher for late gates and assuming a constant scattering coefficient across tissue layers, by using Equation 3-2, we find 
the BF is three times higher in the brain than in the scalp and skull. When comparing the normocapnia and hypercapnia 
periods, the decay rate for early gates doesn’t change significantly, suggesting blood flow in the skin and scalp doesn’t 
change with hypercapnia. Instead the decay rate for late gates increases with hypercapnia. We found that an increase in 
end-tidal CO2 from 35 to 45 mmHg results in an increase in blood flow of 55%. 
 
Discussion 
We have introduced a novel method for simultaneous TD-NIRS and DCS 
measurements which synergistically exploits TD photon time-of-flights to calculate time-
gated DCS correlation functions.  Time-gates for the correlation functions are 
implemented in parallel using TCSPC, enabling the use of narrow time gates without 
sacrificing photon efficiency. The width of the time gates has a larger influence in TD-
DCS than in TD-NIRS, since the TD-DCS signal depends not only on the magnitude of 
the detected light but also on its coherence. We show that narrow time gates of duration 
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less than the duration of the laser pulse increases the amplitude of the correlation 
functions, which is essential for overcoming the loss in SNR due to the intrinsically lower 
coherence of a pulsed source. Furthermore, the narrow time gates result in a direct 
measurement of the path-length dependent correlation functions, which are obscured by a 
convolution with the path-length distribution in conventional CW-DCS methods. The 
decay rate of path-length dependent correlation functions are independent of the optical 
absorption coefficient of the media, which has the potential to reduce uncertainty in the 
estimation of blood flow. Prior demonstrations of path-length resolved DCS relied on the 
selection of individual path-lengths by non-linear optics (Yodh et al 1990) or 
interferometry (Borycki et al. 2016) limiting throughput and applicability for in vivo 
measurements. Here, we have taken the novel approach of exploiting the path-length 
dependent correlation functions to improve the sensitivity of transcranial blood flow 
measurements to the brain by distinguishing the contributions from short and long paths. 
We overcame the conflicting requirements for pulse duration in TD-NIRS and DCS and 
designed and constructed a new pulsed MOPA source with sufficient coherence and 
power for DCS. We have demonstrated that TD-DCS measurements are practical in live 
animals with a method feasible for human use.  
The current system includes only one color source and two detectors, but it can be 
easily extended to multiple sources and multiple detectors. As in NIRS, sources of 
different wavelengths can be used to quantify concentrations of oxygenated and 
deoxygenated hemoglobin, which when combined with blood flow will enable estimation 
of oxygen consumption. Multiple detectors can be used to perform multi-distance 
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measures or to increase SNR. Importantly, we will be able to exploit the large amount of 
independent information measured by this method and solve the global non-linear 
optimization problem to improve accuracy in determining cerebral hemoglobin 
oxygenation, flow and metabolism.   
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CHAPTER FOUR: NON-INVASIVE MEASUREMENT OF INTRACRANIAL 
PRESSURE BY DIFFUSE CORRELATION SPECTROSCOPY 
Introduction 
Intracranial pressure (ICP) regulation is an important indicator in managing brain 
health during many common neurological disease and injuries. In some pathological 
conditions, such as traumatic brain injury (TBI), an exponential increase in ICP can 
dangerously reduce cerebral perfusion pressure (CPP) and cerebral blood flow (CBF), 
resulting in serious ischemic brain injury or death. Because elevated ICP is an important 
cause of secondary brain injury, and its degree and duration is associated with poorer 
outcome after TBI (Alali et al. 2013) (Stein et al. 2010),  monitoring of ICP is 
recommended for the management of severe TBI (Brain Trauma Foundation et al. 2007). 
Invasive procedures to measure ICP with an intracranial catheter connected to a pressure 
transducer (Lundberg et al. 1959) have the advantages of high accuracy and low-cost but 
the risk of complications such as hemorrhage and infection (Holloway et al. 1996; 
Anderson et al. 2004; Binz et al. 2009) restricts use of this monitor to the most severely 
ill patients. While ICP as a numerical value is widely used in neurocritical care because 
of its ease of measurement and unambiguous physical meaning, the capacity of a patient 
to compensate excess pressure is of greater clinical importance than the value of ICP 
itself (Stocchetti et al. 2014). Cerebral tolerance to pressure varies greatly between 
individuals and even within the same individual it often spontaneously changes without 
warning during the course of common pathological conditions. Thus, a level of ICP that 
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was harmless at one instant may suddenly become harmful or a level well tolerated in one 
person may lead to injury in another.  
Since ICP increases are only a secondary consequence of an underlying primary 
injury, physiological-based measurements, such as those used to estimate ICP non-
invasively, may have greater potential for predicting risk of pressure-related injuries if 
they can assess a tissue’s reactivity to pressure rather than simply replicating an invasive 
measurement of pressure. Measurements of properties of the cerebral blood circulation 
can be promising approaches for physiological assessment of ICP because disruption of 
CBF is the major cause of injury from increased ICP (Werner and Engelhard 2007). 
However, the relationship between CBF and ICP is complicated. ICP is an extravascular 
transmural pressure while CBF is driven by cerebral perfusion pressure (CPP).  
Determination of the CPP is ambiguous because it is actually a pressure gradient 
defined by the difference in intravascular pressure between vessels carrying blood into 
the tissue and those carrying it out. Because CPP is a derived quantity, it is more 
ambiguous than quantities which are measured directly, such as ABP and ICP. The 
consensus is that arterial blood pressure is an acceptable, though unproven, surrogate for 
CPP’s inflow pressure. However, various factors contribute to create an effective 
downstream outflow pressure for CPP which has no precise physical source. Under 
normal conditions, when ICP is less than central venous pressure (CVP), the outflow 
pressure is generally regarded to be CVP, and CPP is defined as CPP = MAP – CVP 
(Greenfield and Tindall 1965). If conditions cause ICP to rise greater than CVP, then ICP 
is conventionally assumed to replace CVP as the effective outflow pressure and the 
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definition of CPP changes to CPP = MAP - ICP. However, the rationale for substituting 
ICP for the outflow pressure is imprecise and remains controversial(Early et al. 1974; 
Weyland et al. 2000). Although this is an approximation, ICP does influence CBF. Illness 
can cause both ICP and MAP to spontaneously change, potentially causing CPP to fall to 
dangerously low levels. Despite the limitations of this approximation to CPP, CPP is 
widely used as proxy for perfusion because it is simple to estimate continuously in real 
time on standard patient monitors (Varsos 2015). In critical care, this measure of CPP is a 
surrogate for the more difficult to measure CBF and could be more accurately replaced 
by a direct measurement of CBF. 
The critical closing pressure (CrCP) of the cerebral circulation is defined as the 
arterial pressure threshold below which cerebral vessels collapse and has been proposed 
as a surrogate measure of ICP. In 1951, Burton postulated the discrepancies between 
predictions of the flow-pressure relationship from Poiseuille’s law for fluid flow in a 
rigid tube and observations of blood flow in the microcirculation could be reconciled by 
considering the vessels as deformable rather than rigid (Burton 1951). While Poiseuille’s 
law states non-zero perfusion pressures will always cause fluid to flow, measurements of 
the cerebral circulation find blood flow ceases at pressures significantly greater than zero. 
The inflow pressure at which flow ceases is designated as the zero flow pressure and 
Burton used Laplace’s law to equate it in blood vessels with the critical closing pressure. 
Transmural pressures can only indirectly change flow by deforming the walls of non-
rigid vessels segments to increase their resistance to fluid flow. Cerebral vessels normally 
have a highly positive, outward-directed transmural pressure gradient, but pathological 
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increases in ICP or decreases in ABP can significantly reduce net transmural pressure. 
For blood pressures greater than the CrCP, the inflating force from blood pressure in the 
vessel balances the superposition of constricting forces from passive elastic tension of 
vessels and surrounding fiber layers, active tension of vascular smooth muscles, and ICP. 
As the difference between blood pressure and the CrCP diminishes, the equilibrium 
diameter of a vessel decreases, causing its resistance to flow to increase. When blood 
pressure is less than the CrCP, constricting forces exceed the inflating force and the 
vessel collapses, inhibiting flow. Through the propensity of deformable vessels to 
constrict and close in response to wall tension and ICP, transmural forces can change the 
hydrostatic pressure inside the vessel. When this pressure is greater than the network’s 
outflow pressure, it effectively replaces the outflow pressure in the perfusion pressure 
gradient and impedes flow. A deformable tube which transduces transmural pressures 
across its walls into the resistance of fluid flow through the tube is flow control 
mechanism known as a Starling Resistor (Permutt and Riley 1963). Burton’s postulate 
implies a portion of the cerebral vascular bed acts as a Starling Resistor and makes the 
amount of cerebral blood flow and the CrCP sensitive to ICP. There is a long standing 
and unresolved debate whether these processes make CrCP or ICP the true downstream 
pressure for determining the CPP (Early et al. 1974; Weyland et al. 2000). If CrCP was 
established to be the correct pressure in determining ICP, its importance as a 
physiological indicator would increase even further. 
Transcranial Doppler ultrasound (TCD) is currently the predominant method used 
to measure cerebral blood flow non-invasively (Cardim et al. 2016a). TCD measures the 
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velocity of blood inflow in large cerebral arteries to estimate regional CBF in the territory 
served by the insonated vessel, which is usually the middle cerebral artery (MCA) 
(Aaslid et al. 1982). TCD can measure both mean and pulsatile blood flow velocities. The 
pulsatility index (PI) is the ratio of the amplitude of pulsatile blood flow to the mean 
blood flow and reflects the effects of ICP on intracranial compliance and blood flow 
pulsatility. Greater pressure pulsatility in turn imparts a greater pulsatility to cerebral 
blood flow. TCD-derived PI during the cardiac cycle and CrCP of cerebral blood flow 
have been investigated extensively as a means to estimate the value of ICP CrCP 
(Czosnyka et al. 1996; Bellner et al. 2004). Unfortunately, factors in addition to ICP, 
such as hypotension and hypocapnia, also influence the value of PI, which limits its 
specificity and makes it the least accurate TCD-based method for estimating ICP (Cardim 
et al. 2016b). Because of the complex and variable response of intrinsic tissues to 
pressure, attempts at non-invasive ICP measurement do not yet have sufficient accuracy 
to be clinically relevant. 
Even after its introduction over sixty years ago, the true significance of the CrCP 
for cerebral physiology remains to be determined and is still an area of active research. 
TCD is the most common method for measuring CrCP but TCD-determined CrCP may 
be susceptible to excessive influence from vessel wall tension in large arteries far 
upstream from circulation in the cerebral parenchyma. Furthermore, TCD has many 
practical issues preventing its use as a critical care monitor. Because of its practical 
importance, CPP is one of the first equations in every textbook on cerebral circulation 
and a mandatory vital sign on every patient monitor in the intensive care unit. However, 
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while the derived quantities of CPP and CrCP have definite physical meanings, they 
remain fairly abstract because the underlying factors necessary for their determination 
cannot be directly measured or even defined anatomically with any precision. To both 
improve basic understanding of cerebral pathophysiology and provide better clinical tools 
for improved neurocritical care, new methods of measuring and interpreting the cerebral 
circulation are needed. 
In this study, we introduce Diffuse correlation spectroscopy (DCS), an all optical 
method for transcranial, non-invasive measurement of microvacular blood flow. DCS is 
distinct from, but complementary to, the more widely used method of near-infrared 
spectroscopy (NIRS). NIRS and DCS both use near infrared light to measure properties 
of blood in the cerebral parenchyma. They also employ a similar measurement geometry 
with light sources and detectors placed on the scalp with a separation of several 
centimeters between them. However, NIRS measures light attenuation because of 
absorption of hemoglobin, while DCS measures how quickly light loses its coherence due 
to the movement of red blood cells (Durduran and Yodh 2014). In DCS, a tissue of 
interest is illuminated by coherent near-infrared light which causes a speckle interference 
pattern to form after the light multiply scatters through the tissue. Dynamic scattering of 
the light by flowing red blood cells causes the speckle pattern to fluctuate rapidly with a 
rate that correlates with the amount of flow. The fluctuations are quantified by measuring 
the temporal intensity autocorrelation curve of light intensity detected from a single 
interference speckle. The decay of the autocorrelation curve is fit with the solution of the 
correlation diffusion equation to determine an index of blood flow (BFi) (Boas and Yodh 
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1997). Since the value of BFi depends on both the speed of moving red blood cells in the 
media and the fraction of scattering events from moving particles, it is reliably 
proportional to actual blood flow and not simply flow velocity as in ultrasound methods. 
Although the units of BFi are in units of cm2/s, rather than the conventional units for 
perfusion of ml / min / 100 g tissue, BFi is reliably proportional to absolute flow, as 
demonstrated in simulations and numerous validation studies against “gold standard” 
measurements (Diop et al. 2012; Jain et al. 2013).  
Until recently DCS has primarily been used to measure mean blood flows (Roche-
Labarbe et al. 2011; Dehaes et al. 2015). Integration times for DCS flow measurements 
have typically ranged from 0.5 to 5.0 seconds, which is too slow to measure pulsatile 
blood flow. We have taken advantage of technological advances in field programmable 
gate array (FPGA) logic devices, high-speed serial buses, and software correlators to 
develop a custom diffuse correlation spectrometer which utilizes continuous-wave photon 
time-tagging for arbitrary calculation of DCS correlation functions. This spectrometer 
enables measurement of blood flow at rates limited by photon statistics. We exploit the 
high acquisition speeds to capture the pulsatile waveform of cerebral blood flow within 
the cardiac cycle. The DCS measurements can be synchronized with measurements of 
ECG, ABP, and ICP to enable determination of derived hemodynamic indices, such as PI 
and CrCP.  
The effects of ICP are important to monitor clinically because prompt treatment 
of dysregulated ICP leads to better outcomes from many common neurological disease 
and injuries. However, ICP is difficult to measure in practice except for patients whose 
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illness is severe enough to justify the surgical placement of an invasive ICP monitor into 
their brains. Even when an invasive monitor is justified, measurement of the pressure 
level alone may not be a sufficient diagnostic to guide treatment because it provides no 
indication of the brain’s susceptibility to injury. Non-invasive monitoring of cerebral 
blood flow has now become a technically feasible alternative or adjunct to monitoring 
ICP. CBF has the potential to be a superior treatment diagnostic for brain injury because 
CBF directly measures the impact of ICP on brain physiology. However, the relationship 
between ICP and CBF is complicated, with many studies published over the years 
investigating their mutual coupling and the origins of the CrCP. CBF-derived CrCP may 
be a more useful measurement than ICP because the CrCP provides information about the 
compensatory reserve of the cerebral vasculature and can be determined non-invasively. 
TCD is the most common method for measuring CrCP but TCD-determined CrCP may 
be susceptible to excessive influence from vessel wall tension in large arteries far 
upstream from circulation in the cerebral parenchyma. Furthermore, TCD has many 
practical issues preventing its use as a critical care monitor. We introduce DCS as a new 
method to measure CrCP because DCS measures a different vascular compartment than 
TCD, which may make DCS-determined CrCP more closely related to ICP than TCD-
determined CrCP. Even if CrCP from DCS and TCD are found to be identical, DCS is 
more practical for continuous clinical monitoring. Combining DCS measurements of 
CBF with NIRS measurements of CBV creates new opportunities for development of 
comprehensive hemodynamic-based diagnostic indicators to assist treatment of brain 
injury and disease during critical care. 
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Methods 
Theoretical Considerations 
Poiseuille’s law establishes a linear relationship between fluid flow and perfusion 
pressure in a rigid tube (Figure 4-1): 
𝐶𝐶 = (𝑃𝑃𝑎𝑎𝑣𝑣𝑎𝑎𝑎𝑎𝑎𝑎 − 𝑃𝑃𝑣𝑣𝑎𝑎𝑜𝑜𝑜𝑜𝑎𝑎𝑎𝑎) �𝜋𝜋𝑎𝑎48𝜇𝜇𝜇𝜇� ≡ (𝑃𝑃𝑖𝑖𝑛𝑛𝑙𝑙𝑖𝑖𝑜𝑜−𝑃𝑃𝑣𝑣𝑖𝑖𝑠𝑠𝑠𝑠𝑖𝑖𝑙𝑙)𝑅𝑅     (Equation 4-1) 
Where Pinlet is the intravascular pressure in the inlet of the vascular segment, Pvessel is the 
intravascular pressure at the location along the segment where the flow (F) is measured, 
and the resistance to flow (R) is defined by the factor consisting of the viscosity (µ) of the 
fluid, the length of the vessel segment (L), and the radius of its internal lumen (r): 
𝐶𝐶 ≡
8𝜇𝜇𝜇𝜇
𝜋𝜋𝑎𝑎4
         (Equation 4-2) 
For the cerebral circulation, Poiseuille’s law is expressed in terms of CBF and 
CPP simply as: 
𝐶𝐶𝐶𝐶𝐶𝐶 = 𝑟𝑟𝑃𝑃𝑃𝑃
𝑟𝑟𝑉𝑉𝑅𝑅
         (Equation 4-3) 
where CVR is the lumped-equivalent cerebrovascular resistance to flow, which, due to 
both vascular elasticity and the action of active regulatory mechanisms, is itself a 
complex quantity of flow and pressure. From this relationship, CBF ceases when CPP is 
zero. 
 Measurements of the dynamic flow pressure relationship have long been used to 
investigate the behavior of blood flow in vessels. When rapid changes occur in CBF or 
CPP, the response of the complementary quantity can be measured before regulatory 
mechanisms have time to adapt and change the amount of CVR. If the changes occur 
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faster than regulatory response times, the influence of active regulation is successfully 
eliminated and CVR remains constant during the measurement.  
The original argument introducing the CrCP was developed by Burton (Burton 
1951) and was further elaborated by Burton and Stinson (Burton et al. 1960), Permutt and 
Riley (Permutt et al. 1963), Aaslid (Aaslid 1992), and Panerai (Panerai 2003). Briefly, 
vessels are also subject to Laplace’s law: 
𝑇𝑇𝜇𝜇𝑎𝑎𝐿𝐿𝑎𝑎𝑎𝑎𝑡𝑡𝑎𝑎 = (𝑃𝑃𝑣𝑣𝑎𝑎𝑜𝑜𝑜𝑜𝑎𝑎𝑎𝑎 − 𝑃𝑃𝑎𝑎𝑎𝑎𝑜𝑜𝑜𝑜𝑜𝑜𝑎𝑎) ∗ 𝑠𝑠 ≡ 𝑃𝑃𝑎𝑎𝑎𝑎𝑎𝑎𝑣𝑣𝑜𝑜𝑒𝑒𝑜𝑜𝑎𝑎𝑎𝑎𝑎𝑎 ∗ 𝑠𝑠    (Equation 4-4) 
where Ptransmural is really the pressure gradient defined by the pressure difference between 
the inside and outside of the vessel, Ptissue is ICP for cerebral vessels, and r is the same 
vessel radius in Poiseuille’s law. For the vessel to have a stable equilibrium without 
rupturing, TLaplace must be balanced by an equal opposing tension provided by the 
intrinsic elasticity of the vessel and its sheath, and, in the case of muscularized vessels, 
the active tension produced by the muscle layer. Active muscle tension always acts to 
reduce the equilibrium radius, while the direction of elasticity forces depends on the 
relative size of the equilibrium radius. The balance of wall and fluid forces establishes an 
equilibrium vessel lumen radius which varies with the transmural pressure gradient. 
Originally Burton derived equilibrium diagrams by graphically solving for the 
equilibrium radius at given pressure according to the intersection of Laplace’s law and 
vessel elasticity diagrams empirically measured from ex vivo preparations of human 
vessels. Poiseuille’s law transforms the equilibrium radius determined for each pressure 
into the flow-pressure relationship. When no simultaneous solution exists for the vessel 
radius, the vessel is in a state of collapse and is closed to flow. The closed condition 
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occurs even though conventional perfusion pressure is greater than zero. The pressure at 
which the critical equilibrium radius occurs is both the CrCP in Laplace’s law and the 
zero flow pressure in Poiseuille’s law. When the vessel radius equals the critical vessel 
radius, Pvessel equals CrCP and Laplace’s law becomes: 
𝐶𝐶𝑠𝑠𝐶𝐶𝑃𝑃 = 𝐼𝐼𝐶𝐶𝑃𝑃 + 𝑊𝑊𝑇𝑇        (Equation 4-5) 
Where WT is the net pressure from both elastic and active vessel wall tensions, TLapace/r. 
Thus, active wall tension adds to the effects ICP and increases the propensity for vessels 
to close under the influence of ICP (Figure 4-1).  
The ideal relationship between cerebral blood flow and arterial pressure is therefore 
linear (Figure 4-2). The slope is the reciprocal of the CVR and the intercept is the CrCP. 
Since the change in blood pressure during the cardiac cycle sweeps through a significant 
portion of the curve, measurement of pulsatile blood flow and pressure enables the flow-
pressure relationship to be determined non-invasively. From these measurements, CVR 
and CrCP can be estimated by a variety of means, including simple linear regression, 
frequency domain models, or by statistical analysis.  
Even in the ideal case, CrCP is greater than ICP by an amount determined by 
vessel wall tension. Since wall tension is under active regulation, physiological changes, 
such as vasodilation by CO2, are transduced into changes in CrCP independent of ICP. 
For muscularized vessels, this contribution to CrCP can be significant relative to ICP. 
The real flow pressure relationship is more complex because of the effects of vessel 
elasticity (Figure 4-2). Panerai (Panerai 2003) reformulated a common semiempirical 
model of vascular mechanics (Ursino et al. 1995) to predict the real relationship based by 
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modelling arterioles. Elasticity causes the relationship to become non-linear at low 
pressures. This non-linearity results in an apparent shift in the CrCP when its value is 
estimated from extrapolation of the linear portion of the curve. In vessels with lower 
elasticity, the apparent CrCP is closer to the true CrCP. 
 
Figure 4-1. Relation between perfusion pressure, transmural pressure, and blood flow. Top: According to 
Poiseuille’s law, flow is driven by perfusion pressure, which is the difference in intravascular pressure at the inlet and 
outlet of the vessel, and resistance to flow, which is determined by the diameter of the vessel’s lumen. Bottom: 
Transmural pressure is the difference between the intravascular pressure and the pressure of the tissue surrounding the 
vessel. While transmural pressure does not directly enter into Poiseuille’s law, elevated intracranial pressure reduces 
transmural pressure, which, if a cerebral vessel is deformable, indirectly increases resistance to flow by decreasing the 
vessel’s lumen. Active contractile forces in muscularized vessels create wall tension which also decreases transmural 
pressure via Laplace’s law. For vessels, such as arterioles, which are both muscularized and deformable, the effects of 
ICP and wall tension compound on vessel’s equilibrium diameter. When transmural pressure becomes negative, the 
equilibrium luminal diameter becomes zero indicating the vessel has collapsed. The intravascular pressure at which this 
occurs is the critical closing pressure. Since flow is prohibited in a collapsed vessel the critical closing pressure can be 
equated to the zero flow pressure.    
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Figure 4-2. Panerai’s formulation of the flow-pressure relationship in the cerebral vasculature using Ursino’s 
semiempirical vascular model. 
Custom Fast DCS Device 
We have developed a novel diffuse correlation spectrometer to measure the rapid 
changes in pulsatile cerebral blood flow which occur during the cardiac cycle (Figure 4-
3). Unique aspects of the spectrometer include a custom FPGA-based photon time-
tagging correlator and a high-power, single frequency, distributed Bragg reflector (DBR) 
laser driven by a custom current source. 
The time-tagging correlator records arrival times of individual detected photons 
such that temporal intensity correlation curves of arbitrary integration times can be 
calculated in software from the event stream. This enables great flexibility for 
synchronizing the time and duration of blood flow measurements with fast acting 
physiological processes such as the cardiac cycle or EEG activity. The correlator includes 
four analog-to-digital converter (ADC) channels to record signals from vital sign 
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monitors using the same time base as the photon events. Photon and ADC events are 
routed to a computer via USB 3.0. 
The correlator consists of functional blocks for the photon detector front end, 
analog input and output, FPGA logic, and interface to the USB controller, all 
implemented on custom printed circuit board. The front end of the correlator uses 
comparators to convert incoming detector signals into low voltage logic levels which are 
routed to a Xilinx Spartan 6 FPGA. A custom state machine written in VHDL and 
synthesized for the FPGA maintains a 150 MHz counter to produce event timestamps. 
Upon arrival of a photon or the acquisition of an ADC sample, the state machine creates 
an event record timestamped with the current value of counter and then pushes it onto a 
FIFO for transfer over the USB bus by a Cypress FX3 peripheral controller. 
The computer receives the stream of events and calculates the correlation functions in 
software from the photon arrival times. To facilitate the development of new DCS 
methodologies, we can store the entire event stream received during a measurement to 
disk. Although storing the raw photon events comes at a cost of bandwidth and media 
space, this feature enables analysis of previously measured data with new algorithms in 
ways that would not be possible when the data is pre-averaged or computed before 
storage. When the photon stream is not required for subsequent analysis, storage space 
can be reduced by saving only the autocorrelation results.  
A custom laser driver based on Erickson’s high stability design (Erickson et al. 
2008) was constructed to drive a DBR laser (Photodigm, Inc.) in CW mode at 850 nm.    
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Figure 4-3. The custom hardware designed and built for fast DCS measurements of pulsatile blood flow.  
Autocorrlation curves were calculated in software from the recorded photon 
stream. The correlation curves were fit to a solution of the correlation diffusion equation 
to determine CBFi. ABP and ICP signal from the fiber optics sensors were reconstructed 
from the ADC stream. For the flow-pressure relationship, timing delays between the ABP 
and CBFi were corrected by introducing a time shift between the signals which 
minimized the deviation from linearity in the flow-pressure curve. CrCP was determined 
from the curve by linear regression. 
Animal preparation and measurement protocol 
Two female Sprague–Dawley rats were used in this pilot study. During the 
surgical procedures the animals were anesthetized with isoflurane (2–2.5% v/v) 
administered via a facemask in a gas mixture of 80% air and 20% oxygen. A tracheotomy 
was performed for mechanical ventilation. The left-side femoral artery and vein were 
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cannulated for regular lines. The right-side femoral artery was cannulated with a fiber 
optic pressure sensor (FISO Technologies, Inc.). After these procedures, the animals were 
moved to a stereotactic frame, and mechanically ventilated with 100% O2 mixed with 
varying isoflurane concentrations. CO2 was added to the mixture during hypercapnic 
challenges. A heating pad was used to maintain the animal’s core temperature at 36.5–
37.5 °C. 
For these animals the scalp was surgically removed and two hollow screws were 
placed in the skull to guide cannulas.  In one screw a fiber optical pressure sensor (FISO 
Technologies, Inc.) was placed epidurally to measure intracranial pressure (Murtha et al. 
2012). Surgical tubing connected to a syringe pump was placed in the other screw for 
epidural infusion of artificial cerebrospinal fluid (aCSF) for manipulation of ICP. Care 
was taken to exclude air bubbles during cannula placement. The cannulas were sealed to 
the screws with dental cement. A DCS optode pair consisting of one source optical fiber 
and four detector fiber were placed touching the surface of the skull over the 
somatosensory cortex. The DCS source detector separation was 5 mm. A single set of 
subcutaneous electrodes were placed bilaterally on the torso to record ECG. 
Normal physiology was verified by blood gas analysis for pO2, pCO2, and pH at 
regular intervals. A capnometer (MicroCapnograph 7801C, Columbus Instruments, 
Columbus, OH) was used to record instantaneous expired CO2 levels simultaneously with 
the optical signals. Body temperature, arterial blood pressure, arterial oxygen saturation 
(SpO2), heart rate and ventilation pressure were all simultaneously recorded with the 
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DCS data. All procedures were approved by the Massachusetts General Hospital 
Subcommittee on Research Animal Care. 
Results 
 
Figure 4-4. Representative time traces of pulsatile DCS blood flow, arterial blood pressure, and intracranial 
pressure measured in a rat. CBFi is fit to autocorrelation curves calculated over a procession of fixed time intervals 
without performing cardiac-gated averaging of the correlation curves before fitting. Autocorrelations were calculated 
over a sliding window of 25 ms that advanced at 4 ms intervals. The top panels are under normal conditions and the 
bottom panels are during an infusion of aCSF to experimentally increase ICP. The thin green trace is the ECG signal, 
which is shown for reference for the timing of the cardiac cycle. The value in the lower right corner of the panels is the 
mean value of the waveform.   
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Figure 4-5. Frequency spectra of the CBFi, ABP, and ICP waveforms. The spectra is from the data of Figure 4. Top 
panel is at normal ICP and bottom panel is during elevated ICP. Two peaks are prominent in the spectra, a cardiac peak 
in the range around 6 Hz (360 BPM) and a respiration peak at 0.9 Hz (54 BPM)  
Figure 4-4 shows recordings of CBFi, ABP, and ICP measured in a single rat at 
baseline and during experimentally elevated ICP.  Under both conditions, pulsatility is 
observed in both the ICP and CBFi measurements (Figure 4-5). Pulsations occur at two 
distinct frequencies and their harmonics. Every cardiac cycle causes a pulse in ICP and 
CBFi which create high frequency oscillations similar to those in the arterial blood 
pressure. Respiration causes an additional slow modulation of all waveforms at the 
frequency of the mechanical ventilation. Mean ICP was 4.8 mmHg for the normal 
baseline and 10 mmHg during infusion. The pulsatility index was estimated to increase 
by approximately 30 percent at the higher level of ICP. 
The raw data are shown in greater detail in Figure 4-6 with the time scale 
expanded to the level of the cardiac cycle. The CBFi waveform closely corresponds to 
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the ABP waveform throughout the cycle. In particular, the sharp rise during the initiation 
of systole is clearly captured in the DCS measurement of CBF. During the rapid change 
in flow at peak systole, the CBFi peaks are systematically smaller than the pressure 
peaks. In Fig 7, the bandwidth of the CBFi signal is compared to bandwidth of the blood 
pressure and ICP signals over a larger spectral range. The blood pressure waveform has 
harmonic content in excess of 100 Hz, but the spectrum of the CBFi calculated in Fig 4 
resolves the harmonics only up to the one at 19 Hz. CBFi bandwidth is limited in this 
case by the choice of the 40 Hz sliding window over which the autocorrelation function 
was performed. Other choices for analysis of the same photon would have different 
bandwidth limits, in particular, cardiac-gated average would result in much greater 
bandwidth. The ICP pulse pressure wave contains harmonics going beyond 50 Hz, but 
consists in total of only about half as many harmonics as the blood pressure wave. 
Regardless of whether bandwidth is limited by physiology, as in the cases of ABP and 
ICP, or by analysis, as is the case for the CBFi analysis presented here, the differences in 
the shapes of the peaks in the time traces reflect the differences in harmonic content. 
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Figure 4-6. Overlay of simultaneous CBFi, ABP, and ICP time traces during individual cardiac cycles. Flow 
generally corresponds with blood pressure across the cycle. CBFi rises sharply with pressure at the onset of systole, but 
the flow peaks are significantly smaller than blood pressure peaks. 
 
Figure 4-7. Harmonic content of the pulsatile waveforms. Harmonics of the blood pressure wave continue above 
100 Hz, while pulsations in ICP and CBFi contain much fewer harmonics. The CBFi spectrum was truncated to the 20 
Hz Nyquist limit of the 40 Hz sliding window of the autocorrelation calculation.  
 
We constructed dynamic flow-pressure curves by averaging CBFi from the time 
traces according to the corresponding value of ABF (Figure 4-8). Though the error bars 
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are large, resulting CBFi-ABP curves exhibit a roughly linear relationship between flow 
and pressure. The linear relationship extended throughout the systolic peak, though flow 
linearity at peak pressures was better under the high ICP condition (r2 of 0.91 vs. 0.98). 
CrCP values by linear extrapolation were 4 and 10 mmHg under baseline and elevated 
conditions. 
 
Figure 4-8. Examples of DCS-measured dynamic flow pressure curves under normal and elevated ICP. 
 
Finally, we considered how the choice of µs’ in the fit of CBFi to the DCS 
correlation curves impact the CBFi-ABP relationship. In Figure 4-9, the same underlying 
data was fit multiple times using values of µs’ of 1, 5, and 10 cm-1, which span the 
physiological range of tissue optical properties. Lowering the value of µs’ caused the 
slope of flow-pressure curve to increase, while increasing the value reduced the slope. At 
the same time, a reduction of µs’ caused an increase in the mean value of CBFi and vice 
versa. However, these effects act to cancel each other in the determination of CrCP so µs’ 
has no net impact on the zero flow intercept. The data in Figure 4-9 was analyzed 
differently than the data in Figure 4-8. In Figure 4-9, cardiac gating was used to average 
  
112 
together short interval autocorrelation curves from different cardiac cycles according to 
their position within the cycle before they were fit for BFi. Cardiac-gated averaging of 
the correlation curve before fitting increase the bandwidth because the interval over 
which the correlation is performed can be reduced. Without cardiac-gated averaging, the 
interval must be long enough for the correlation curve to have sufficient SNR to perform 
a fit for CBFi. With averaging, correlations over integration intervals too short to have 
enough SNR for a fit can be accumulated to make fitting possible. In these data sets, the 
CBFi-ABP relationship exhibits hysteresis over the cardiac cycle. In Figure 4-9, linearity 
was maintained by using only the last portion of the cardiac cycle. The values of CrCp 
are negative, which is non-physiological, but also occurs frequently when CrCp is 
estimated by TCD (Varsos et al. 2013). 
 
 
Figure 4-9. Effect of the choice of reduced optical scattering coefficient, µs’, in the fit of CBFi on DCS-measured 
dynamic flow-pressure curves. The same set of DCS data was fit multiple times for CBFi using different assumptions 
for the value of µs’. See text for the details of dataset. The resulting slope and mean CBFi value of the flow-pressure 
curve change reciprocally with the value of the coefficient, but these effects tend to cancel for CrCP. Thus, the absolute 
values of CVR depend strongly on the accuracy of µs’, but estimation of CrCP is unaffected. 
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Discussion 
We have succeeded in creating a new technique for measuring CrCP non-
invasively with diffuse correlation spectroscopy. We demonstrate that our novel 
hardware and software have sufficient bandwidth and sensitivity to measure pulsatile 
cerebral blood flow in small mammals and capture cardiac and respiratory pulsations. 
Our device records other physiological signals, including pulsatile arterial blood pressure 
and intracranial pressure, synchronously with blood flow to assess their 
interdependencies. In particular, simultaneous measurements of pulsatile ABP and CBFi 
are combined to determine the dynamic flow-pressure relationship and the CrCP. We 
establish DCS-measured CBFi of cortical microvasculature obeys the expected linear 
relationship between cerebral blood flow and blood pressure during the cardiac cycle. We 
demonstrate DCS can measure flow-pressure relationships under different pathological 
conditions and the resulting estimation of the CrCP changes with the level of ICP. This 
new DCS technique for those physiological assessments of the cerebral vasculature and 
intracranial pressure has potential to be comparable to TCD-based methods. 
Measurements of the dynamics of intracranial fluids use cardiac and respiratory 
cycle pulsatility as benchmarks of measurement performance (Murtha 2012). Both types 
of pulsation were clearly visible in our DCS measurements of cerebral blood flow at both 
normal and elevated ICP. Pulsatile CBFi is dominated by cardiac flow, as expected. 
Slower respiratory pulsations of CBF originates from a portion of the respiratory cycle 
where intrathoracic pressure increase and impedes venous return to the heart. This 
  
114 
pressure cycle modulates the amplitude of the faster cardiac pulses in the ABP, ICP, and 
CBF. Increasing the ICP increased the pulsatility of CBFi. 
Small mammals have fast heart rates, which creates technical challenges for 
measuring pulsatile flow. Despite the fast rates, CBFi waveforms exhibited good 
correspondence with ABP waveforms except at the region of peak systolic flow. This 
apparent discrepancy could either be technical or physiological. TCD measurements of 
cerebral blood flow velocity in the MCA do not show this discrepancy, suggesting our 
DCS measurement or analysis did not have sufficient bandwidth to capture the peak 
dynamics in the rat. If the measurement bandwidth is insufficient, frequency domain-
based methods of analysis for CrCP cannot be used. However, TCD measures flow 
velocity in large vessels with strong pulsations while DCS measures flow in the 
microvasculature where pulsations may be weaker. Pulsation absorption of microvascular 
flow by brain tissue might therefore be an alternate explanation for the discrepancy based 
on physiology. Classically, pulsatility absorption plays a large role in the generation of 
ICP waveforms. Indeed, in our measurements the ICP pulse wave was also not as sharply 
peaked at systole as ABP. We examined the frequency response of all three waveforms 
and found the harmonic content of ICP and CBFi waveforms was less than that of the 
ABP waveform. In the case of ICP, attenuation of high frequencies occurs due to natural 
pulsation absorption by brain tissue. For the case of CBFi, the attenuation may arise from 
either physiological absorption or may simply be a technical artifact. The data analysis 
presented here cannot fully distinguish these possibilities. The sharp roll off towards 20 
Hz in the CBFi spectra indicates the artifact of the 40 Hz bandwidth of the analysis at 
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least partially contributes to the difference. Fortunately, the temporal resolution of this 
data set could be improved by reanalyzing the saved photon stream with an algorithm 
which averages the correlation curves by cardiac-gating before fitting them for CBFi. 
This alternate analysis method increases the temporal resolution of CBFi determination 
by reducing the minimum period over which correlation is performed. However, to do so 
correctly, the position of the correlation period in the cardiac cycle must be accurately 
determined to enable periods from the same position to be averaged over multiple cardiac 
cycles without distortion. The effects of the slow respiratory cycle in the blood flow must 
also be accounted for properly. Since the underlying data remain the same, comparison of 
the harmonic content of the new analysis with the one presented here would determine if 
attenuation of peak systolic flow seen here is a limit of the analysis bandwidth or may be 
physiological. Regardless of the analysis algorithm, our methods will have superior 
temporal performance in humans because their much slower cardiac cycles reduce 
measurement bandwidth requirements. Overall performance in humans remains to be 
determined fully, as the gain in temporal resolution of the slower human cardiac cycle 
may be offset by reductions in SNR from influences of the thicker extracerebral layers in 
humans and the greater source-detector separations needed to reach human brain. 
The bandwidth of the measurements presented here is sufficient to observe the 
relationship between CBFi and blood pressure in the rat. When ICP was elevated, the 
relationship remained linear. CrCP also increased with ICP in qualitative agreement with 
the expected shift. Our results demonstrate using DCS to measure ICP noninvasively is 
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feasible in principle. Future work will quantify the accuracy of DCS to assess its utility in 
practice. 
Because DCS is an optical based method, a few considerations apply that have no 
correspondence in TCD. The bandwidth of DCS measurements are limited by shot noise 
and the distribution of photon arrival times. Shot noise must be also be taken into account 
when statistical methods are used to determine CrCP. DCS methods are also influenced 
by signals of extra cerebral origin from the scalp. Furthermore, the absolute values of 
CBFi depend on the optical scattering and absorption properties of the tissue. In the fit for 
CBFi using the correlation diffusion equation, µs’ multiplies the factor for CBFi so errors 
in µs’ translate linearly into errors in CBFi. We find the choice of the value of µs’ in the fit 
propagates to systematic changes in the CBFi-pressure relationship, but do not impact 
zero flow crossing determination of the CrCp. Absolute values of CVR are highly 
influenced by the choice of µs’ while determination of CrCP remains robust. 
DCS and TCD measure fundamentally different types of cerebral blood flow. 
TCD measures blood flow velocity in the cerebral arteries supplying circulation to large 
brain territories, while DCS measures flow within the microvasculature of the cerebral 
parenchyma. Since DCS measures actual flow rather than the flow velocity measured by 
TCD, DCS is immune to the artifacts that changes in vessel diameter cause in TCD. 
Furthermore, DCS measures total flow, a combination of both inflow and outflow, while 
TCD measures inflows only. TCD, by measuring the aggregate blood supply of many 
anatomically distinct regions, potentially averages together flow responses of vasculature 
with different sensitivities to ICP. DCS measures blood flow locally in the 
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microcirculation of cm3-sized volumes of cortical tissue with results weighted towards 
flow in small blood vessels. These small vessels have less wall tension and elasticity than 
the muscularized cerebral arteries probed by TCD. Therefore, vessel wall tension may 
have less of an influence on DCS measurements than on TCD measurements. The 
differences between the two techniques may lead to significantly different interpretation 
of their results. 
DCS has many practical advantages over TCD. TCD requires a skilled operator 
who can find and keep the correct cerebral artery segment properly insonated during the 
measurement. Regardless of the expertise of the operator, no TCD measurements are 
possible at all for about 15 percent of the general population because natural anatomical 
variations in bone thickness block ultrasound from penetrating the skull sufficiently. The 
bone structure demographics can be considerably worse for certain populations. For 
example, TCD measurements are not possible for a majority of Asian women (Chi 2016). 
Furthermore, quantitative TCD results depend on the angle of insonation of the cerebral 
artery. Improper orientation of the TCD probe will bias measured flow values while 
changes in orientation during measurement cause flow values to fluctuate erroneously. 
Even with the assistance of mechanical head frames, TCD measurements are performed 
only episodically and for limited duration. Analysis of TCD waveforms is complicated 
and requires significant expertise and experience to provide a reliable estimate of blood 
flow velocity. In contrast, DCS measurements can be performed in every patient, ranging 
from premature neonates to the elderly, by placing a simple probe on the scalp. The DCS 
probe produces accurate measurements independent of orientation and can be used at 
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different locations on the head for regional CBF measurements. However, DCS blood 
flow measurement are limited to cortical regions because of limits of the depth of light 
penetration into the head. Unfortunately, the extracerebral layers also contribute to pCBF 
signals, limiting accuracy and sensitivity to cerebral blood flows. This is the biggest 
weakness of DCS and, although different than TCD’s problems with thickness 
transtemporal window, is similarly challenging. Performing DCS measurements is no 
more difficult than using a cerebral oximeter. Automated calculation of BFi makes blood 
flow values available in real-time as a vital sign similar to SO2 which can be interpreted 
at the bedside by ordinary doctors and nurses. The simplicity of the DCS probe enables 
continuous monitoring for extended, multi-day periods of time. DCS is also compatible 
with simultaneous NIRS measurements of hemodynamics in the same cortical region 
where CBF is measured by DCS. Simultaneous DCS and NIRS measurements enable 
investigation of the dynamic relationship between pulsatile CBF and CBV, which are 
associated with both physiological and pathological changes in compliance. NIRS and 
DCS measured together also enable determination of cerebral oxygen metabolism 
(CMRO2) (Lin et al. 2013; Roche-Labarbe et al. 2013). 
Estimation of ICP from TCD measurements of the CrCP uses the natural change 
in blood pressure during the cardiac cycle to intrinsically probe the flow-pressure 
relationship in the cerebral circulation (Aaslid et al. 1991). Since the CrCP is the sum of 
both ICP and vessel wall tension, CrCP’s specificity for ICP depends on the properties of 
the vascular segments which respond to external transmural pressure. Conceptually, these 
segments act as Starling resistors to transduce changes in ICP into changes in CrCP. 
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However, Starling resistors in the cerebral circulation are postulated simply as 
hypothetical constructs to rationalize the observed relationship between blood flow and 
pressure in the microcirculation. Their existence remains controversial and alternative 
hypotheses have been proposed to explain the flow-pressure relationship (Magder 1990). 
Observations in humans of the cessation of cerebral blood flow velocity during diastolic 
portions of the cardiac cycle when blood pressure pathologically dropped below the CrCP 
provides strong evidence for the Starling resistor-based mechanism (Varsos 2014; Rhee 
2015). However, efforts to identify specific anatomical structures in the cerebral 
circulation as physical manifestation of Starling resistors have been inconclusive (Auer 
1987). It is likely if Starling resistors do exist that they are actually a vague composite of 
various elements of the circulatory system. Therefore, estimations of the CrCP potentially 
depend on the methods used to measure CBF, since different methods give different 
weight to the amount of flow in each vascular compartment. While TCD-measured CrCP 
is a more accurate indicator of ICP than TCD-measured PI, it is also not yet sufficiently 
accurate for clinical use (Cardim et al. 2016b). At low levels of ICP, TCD-measured 
values of CrCP are systematically greater than ICP, suggesting the TCD measurements 
are biased by contributions from vessel wall tension(Weyland et al. 2000). At high levels 
of ICP, the effects of external transmural pressure dominate over the effects of wall 
tension and the values of TCD-measured CrCP more accurately match the values of ICP, 
suggesting if the effects of wall tension could be minimized, the CrCP could be a viable 
method for estimating ICP. Additional evidence for the influence on wall tension on 
TCD-measured CrCP comes from the effects of arterial CO2 (paCO2), which cause the 
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values of CrCP to change independently of ICP(Weyland et al. 2000). The dilatory 
effects of arterial CO2 modulate arterial wall tension and presumably it is this change in 
tension, not blood volume related change in ICP, which is responsible for the ICP-
independent changes in CrCP. Therefore, the sensitivity of CrCP to paCO2 is a measure 
of the amount arterial wall tension contributes to the measurement of the CrCP. In TCD 
studies, the coefficient of CrCP sensitivity to paCO2 is consistently measured to be about 
-1.5 mmHg CrCP / mmHg paCO2 (Panerai 2003). The coefficient’s large negative value 
is additional evidence that wall tension, specifically arterial wall tension, makes 
significant contributions to TCD-measured CrCP. Future work will be to measure the 
value of the coefficient for DCS-measured CrCP. In addition to tension, vessel elasticity 
also influences the flow-pressure relationship (Ursino et al. 1995). Measurements of 
inflow in experimental preparations of large arteries find arterial pressure continues to 
decrease after inflow rates are brought to zero because the capacitance of elastic arteries 
cause outflow to continue after inflow ceases. TCD, by measuring only the velocity of 
inflows, may be susceptible to artifacts due to vessel elasticity. While CrCP has been 
established as a potential avenue for assessing ICP non-invasively, limitations in TCD-
derived measurements justify the development of alternative means to measure pulsatile 
CBF and determine CrCP non-invasively. 
Measurements of flow-pressure relationships will be dominated by the rate 
limiting segments in the vascular tree. Despite the greater elasticity of other vessel, 
arterioles may be the dominate source of Starling resistor effects in the cerebral 
circulation because they are subject to both ICP and active wall tension from their 
  
121 
vascular smooth muscles. Based on their TCD measurements, Weyland, et al. propose 
two such sites may exist in series in the cerebral circulation, an arteriole Starling resistor 
which dominates the relationship by virtue of its greater wall tension and a venous 
Starling resistor which is the least stiff segment in the tree and is more sensitive to ICP. 
DCS, by measuring a different distribution of circulatory compartments, may have 
different sensitivities to the putative resistors than does TCD. 
Conclusion 
We have developed a novel, custom diffuse correlation spectrometer for high-
speed blood flow measurements. We demonstrate measurement of the pulsatile cerebral 
blood flow in small mammals is feasible and, for the first time, that CrCP and PI can be 
successfully determined by DCS. We show DCS-measured CrCP is sensitive to changes 
in ICP through artificial manipulation in experimental preparations. We show these 
methods are practical for measurements on patients in the neurointensive care unit. We 
conclude DCS is a viable alternative to TCD for non-invasive measurement of pulsatile 
cerebral blood flow and determination of dynamic flow-pressure relationships. Future 
work will determine the applicability of DCS-measured CrCP as a non-invasively 
measured surrogate for ICP.  
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